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Abstract

While the primary biochemical targets of B-lactams have been
identified, the mechanisms by which inhibition of these targets
(the membrane bound penicillin-binding proteins, or PBPs) leads
to the irreversible antibacterial effects of these drugs have
remained elusive. Treatment of Streptococcus pneumoniae with
penicillin (or other cell wall inhibitors) results in a rapid
sequence of events beginning with a slow-down and brief halt in
bacterial growth, followed by rapid and irreversible reduction in
the reproductive capacity (killing) of the cells, plus massive
degradation (depolymerization and release) of the cell wall
sacculus and release of cytoplasmic contents (bacterial lysis).
By the end of the 1970s, a large body of observations clearly
indicated that all these pathological events observable in
penicillin-treated bacteria were secondary, indirect consequences
of the inhibition of the primary (enzymatic) targets of
penicillin (84). Exactly how and why inhibition of PBPs leads to
slow-down and inhibition of growth followed by viability loss and
lysis (in some bacteria and under some experimental conditions)
has remained poorly understood. However, in pneumococci, the
phenomenon of penicillin-induced cell wall degradation and lysis
has been shown to result from the (drug-induced) deregulated
activity of the pneumococcal major autolytic enzyme, a Nacetylmuramyl-L-alanine amidase (referred to as amidase)(80). The
concurrence of culture lysis and loss of viability in these
organisms has led to the widely held belief that the cause of
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cell death was the unregulated (suicidal) activity of bacterial
autolysins. On the other hand, in certain bacteria, penicillin
can have powerful bactericidal activity without accompanying cell
lysis (e.g., pneumococcal mutants with inactivated amidase (lytA)
gene (80) and group A streptococci), suggesting that mechanisms
other than bacterial autolysis may exist for the cidal effect of
this antibiotic. We have investigated the existence of such
autolysis-independent lethality in pneumococci. The results of
these experiments are presented in four Chapters to be summarized
next.
Chapter I describes three types of experiments which suggest
that only part of the penicillin-induced lethality is due to
autolysis by amidase. (i) Suppression of penicillin-induced lysis
by specific inhibitors of amidase protects pneumococci only
marginally from killing, (ii) Mutants from which the amidase was
completely eliminated by insertion-inactivation or deletion of
the lytA gene are still killed, albeit at a slower rate than the
wild-type Lyt+ strains, (iii) A new mutation (cid) , not related
to the amidase gene (lytA), causing massive reduction in killing
was identified and characterized. "Triggering" of the amidase
activity by penicillin in situ in growing bacteria is
significantly reduced in the presence of the novel cid' mutation,
indicating that there is a regulatory interaction between the cid
gene product and the amidase
Chapter II, describes several attempts to characterize the
cid' mutation at the molecular level. Shotgun mutagenesis by
insertion-inactivation (using either insertion-duplication or
vi

transposon mutagenesis) failed to yield Cid" mutants, suggesting
that null-mutants in the cid determinant(s) might not be viable.
The possibility that cid is an essential gene is supported by the
observation that cidr mutants had an extra nutritional
requirement, inseparable in genetic crosses from the cid'
mutation itself (i.e., growth of cidr mutants in a chemically
defined medium required supplementation of the medium with a 5001000 kD molecular weight molecule present in yeast extract).
Chapter III presents a step-by-step biochemical comparison
of the principal penicillin targets of wild-type Cid+ parents and
Cid" pneumococcal mutants, including the penicillin-binding
proteins, the major autolysin amidase and the cell wall
peptidoglycan. Physiological experiments suggest that cidr
mutation is likely to operate at the level of the plasma
membrane.
Genetic blocks in the lytA (amidase) and cid genes can
prevent both of the irreversible antibacterial effects of
penicillin (lysis and killing) in pneumococci. Yet, these
bacteria remain exquisitely sensitive to the drug, but addition
of the antibiotic only causes inhibition of growth. The
availability of the Cid" Lyt" double mutants allowed us to look
closer at the mechanism of this reversible growth inhibitory
effect of penicillin and Chapter IV describes studies in this
direction. These studies show that penicillin treatment of both
Cid+ and Cid" pneumococci results in the shutoff of protein and
RNA synthesis, through some as yet unidentified regulatory
circuit in the cells. In addition, antibiotic-treated pneumococci
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induce and or continue the specific radioactive labeling of a
unique 72 kD protein with [35S]-cysteine, even when incorporation
of radioactive amino acids in all other protein species has come
to a virtual halt. The mechanism of radioactive labeling of the

72 kD protein in response to inhibition of synthesis of bacterial
biopolymers is likely to involve addition of [35S]-cysteine to a
preexisting protein through peptide bonds. The 72 kD species is
also labeled in response to treatment with some other
antibiotics, mechanistically unrelated to penicillin, but not
during heat-shock. The 72 kD protein might be an "stress factor"
implicated in the regulatory circuit mediating metabolic idling
during antibiotic treatment.
Taken together, the results presented in this dissertation
underline the complexity of the pneumococcal response to
treatment with penicillin. Analysis of Lyt" and Cid" mutants and
double mutants has allowed a glimpse into several distinct
pathological processes that are related to antibiotic-induced
disintegration, viability loss, while the discovery of the 72 kD
"stress factor" may serve as a signal for halt in growth and
turning off cellular biopolymer synthesis. The major conclusion
of the thesis work is that the primary mechanism of penicillininduced lethality is not bacterial lysis. It appears that during
penicillin treatment of wild-type (Cid+ Lyt+) pneumococci, the
bacteria are first killed and then lysed. Antibiotic-induced
killing appears to be mediated by an alternative - membranerelated - mechanism, which can be influenced by mutation(s)
(cid~) independent of the determinant (lytA) of the major
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autolysin amidase. The interaction between the bacterial
autolysis and the cid

product may be analogous to the model

proposed for the interactions between the membrane-active
"channel" proteins (holins) and endolysins in bacteriophageinduced lysis of bacteria (57,96).

ix

TABLE OF CONTENTS
page
ACKNOWLEDGEMENTS iii
SUMMARY V
TABLE OF CONTENTS X
INTRODUCTION 1
The bacterial challenge to B-lactam antibiotics antibiotic resistance and tolerance 1
The bacterial target of B-lactams 4
Functional anatomy of penicillin-binding proteins (PBPs) 4
PBP-inhibition by penicillin 6
Generic formula of penicillin and cephalosporin 6
Kinetics of PBP-inhibition by penicillin 7
The family of penicillin-interacting proteins ..... 9
The journey of the antibiotic to its cellular target... 10
Methicillin resistance in staphylococci 12
Physiological consequence of PBP-inhibition 12
The irreversible effect of B-lactams 13
The bactericidal mechanism of penicillin 15
The non-lytic bacterial death 18
The search for the killing target 19
Outline of the thesis 20

CHAPTER I 22
Summary of results 22
Materials and Methods 24
In situ inhibition of amidase 26

X

Selection for kill-resistant mutants
Genetic transformation 28
Results 31
Effect of autolysis inhibition on killing by penicillin 31
Selection of kill-resistant mutants 35
Characterization of kill-resistant mutants 36
Genetic characterization of the cidr mutation 38
Discussion 47
A model for the interplay of cid and lytA (figure 6) .. 50

CHAPTER II 51
Summary of results 51
Materials and Methods 52
DNA preparation and fractionation 53
Conjugation and transformation 54
Results 57
Insertion-duplication mutagenesis 57
Mutagenesis with Tn2545 and Tn926 62
Gene conversion 62
Discussion 69

CHAPTER III 74
Summary of results 74
The principle penicillin targets of the cell (fig. 9).. 76
Materials and Methods 77
Titration of PBPs 77
Preparation of cell walls 77

xi

27

Preparation of cell extracts
Hydrolysis of cell walls 81
Results 82
Titration of PBPs 82
Susceptibility of purified walls to amidase digestion.. 82
Analysis of the cell wall structure 85
Specific activity of murein hydrolases 86
Mutants with an increased "nicking" enzymatic activity. 88
Interference of cid~ with lysis of lived pneumococci... 90
Penicillin-induced degradation of RNA 93
Survival of penicillin-induced protoplasts 93
Discussion 94
A model for penicillin-induced killing (figure 13) 99

CHAPTER IV 100
Summary of results 100
Materials and Methods 102
Drug treatment and heat-shock 103
Rates of protein and RNA synthesis 104
Radiolabeling of proteins and SDS-PAGE separation 105
Protein analysis 107
Results . 109
Kinetics of growth inhibition by penicillin 109
Inhibition of protein synthesis by penicillin Ill
Radioactive labeling of a unique 72 kD protein 115
Characterization of the 72 kd protein 118
Regulation of the labeling of the 72 kD protein 122

xii

79

Labeling of the 72 kD protein in other conditions

125

Discussion 130

APPENDIXES 135
I. Additional characteristics of a Cid" mutant 135
II. Control experiments for a system of gene conversion.... 139
III. Structural analysis of cell walls 141
IV. Pneumococcal mutant overproducing a "nicking" enzyme... 144
V. Penicillin-induced degradation of RNA 148
VI. Survival of penicillin-induced protoplasts 151
VII. PBP determination in Cid* and Cid" cells (figure) 154
VIII.Localization of the 72kD protein in cell fractions 155

SUMMARY AND CONCLUSION 156

REFERENCES 169

xiii

Introduct i on

I.

The bacterial challenge to B-lactam antibiotics - antibiotic

resistance and tolerance.

Over 50 years after the introduction of penicillin in human
medicine (2), B-lactam antibiotics remain one of the most
important groups of molecules in the armamentarium of
antibacterial agents. The key to this success resides in the fact
that these compounds specifically inhibit critical steps in the
synthesis of the essential bacterial cell wall peptidoglycan, a
structure uniquely conserved among eubacteria. This restriction
renders 6-lactam antibiotics highly toxic for bacteria
synthesizing peptidoglycan, while being remarkably harmless for
other organisms. For example, 6 ng of penicillin/ml are
sufficient to inhibit bacterial growth of a penicillinsusceptible strain of Streptococcus pneumoniae, whereas up to
100,000 ng of penicillin/ml of serum can be achieved during
intravenous treatment of animals without any harm for the
recipient. The necessary presence of peptidoglycan for the fullblown toxicity of B-lactam antibiotics is also demonstrated by
the fact that bacteria devoid of this particular structure (such
as mycoplasma, archaeobacteria and L-forms of bacteria) are
insensitive to these compounds.
An additional very important feature of B-lactam antibiotics
is their bactericidal activity. Bacterial killing is an absolute
1

requirement for successful treatment of infections in conditions
of impaired or absent host defense mechanisms. Such infections
are not limited to the "classical" bacterial meningitis or
endocarditis, in which the infection is confined to anatomic
sanctuaries quasi devoid of phagocytes or other cellular host
defense mechanisms. They now also encompass a new spectrum of
bacterial diseases in the increasing number of patients with
immune defects, including both the so-called acquired immune
deficiency syndrome (AIDS) as well as patients with other
underlying conditions such as anticancer chemotherapy.
Not surprisingly, during the past decades bacteria have
evolved a number of sophisticated mechanisms to escape the
bacteriostatic and/or bactericidal effect of B-lactam
antibiotics. These can be broadly separated in two classes: (i)
antibiotic resistance and (ii) antibiotic tolerance. Resistant
bacteria are characterized by the fact that they can continue to
grow in the presence of concentrations of antibiotic that may be
far above the threshold that inhibits multiplication of most
(i.e., the susceptible) members of the same species, the minimal
inhibitory concentration, or MIC. Nevertheless, above this new elevated - threshold concentration, resistant bacteria again
respond to the killing (and lytic) effects of the drug. Tolerant
bacteria, in contrast, retain the MIC value characteristic of
susceptible strains, but become dramatically altered in their
response to drug-induced killing and/or lysis - i.e., they are
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able to "survive" drug treatment (29,49,57,85,86)x.
The antibiotic pressure operating in the clinical
environment selects for both tolerant and resistant bacteria
(49,58). In such an environment, antibiotic tolerance, i.e., the
ability to survive antibiotic treatment, is likely to provide
bacteria with a tremendous advantage to equip themselves with
resistance genes, either by spontaneous mutations or by DNA
exchange. Therefore, in view of the contemporary alarming spread
of antibiotic resistance to virtually all known antibiotics (64),
the potential importance of antibiotic tolerance is evident.
Hence, it is of the utmost importance to understand the
mechanism(s) and the nature of the cidal damage(s) inflicted by
B-lactam antibiotics to the bacterial cell.
In the following, I shall briefly overview our current
perception of the mode of action of B-lactam antibiotics and the
physiological consequences of inactivation of their specific
targets, the membrane-bound penicillin-binding proteins (PBPs). I
shall also present evidence arising from both natural and
laboratory isolates of bacteria which suggest that antibioticinduced bacterial lysis might not be, as widely believed, the

^Tolerance can either result from "survival" mutations
(genotypic tolerance) or can be naturally expressed in conditions
of slow bacterial growth (phenotypic tolerance) (85). In contrast
to the latter, genotypic tolerance is expressed during the whole
cycle of bacterial growth and is transmitted both vertically to
the bacterial progeny and horizontally to other cells by DNA
transfer (57). Mutations that confer antibiotic tolerance or
resistance are mechanistically and genetically independent
(49,57).
3

major bactericidal lesion produced by penicillin treatment in
pneumococci.

II. The primary bacterial targets of B-lactam antibiotics:
membrane-bound penicillin-binding proteins (PBPs)

Penicillin-binding proteins (PBPs) are the primary bacterial
targets of B-lactam antibiotics. They are membrane-bound enzymes
which are essential for the assembly of the cell wall
peptidoglycan. PBPs have been the subject of extensive research
and have been reviewed in the literature (13,23,76,79). The
following overview is a non-exhaustive summary of the current
understanding of the PBP-B-lactam interaction, to the extent that
is relevant for the subject of this presentation.

(i) The functional anatomy of penicillin-binding proteins: PBPs
are members of a larger family of so-called penicillininteracting molecules, which share the ability to bind penicillin
and catalyze the rupture of the lactam amide bond and transfer
the penicilloyl moiety to an essential serine, forming a serineester-linked acyl derivative (see generic formula [1] and figure
1 on p. 6 and 8 resp.). Each bacterial strain contains a specific
set of PBPs, the number and molecular size of which are highly
conserved and may even be used for taxonomic purposes. Depending
on the organism, a bacterium may contain up to 2,000 PBP
molecules. In a given strain, PBPs of different molecular sizes

4

are numbered from the largest to the smallest molecule.
High molecular weight PBPs (e.g., PBP 1 to 3 in E. coli) are
believed to be important enzymes that catalyze the final stages
of peptidoglycan synthesis. Some of these proteins (but perhaps
not all) are bifunctional enzymes that catalyze both a
penicillin-insensitive peptidoglycan transglycosylase and a
penicillin-sensitive transpeptidase activity (63A) and are
anchored to the membrane through a hydrophobic N-terminal segment
(76, 76A)2. In contrast, known PBPs of low molecular weight
(e.g., PBP 5 of £. coli) are anchored to the membrane through a
carboxy-terminal hydrophobic segment, and contain only a
"peptidase" extracellular domain (for review see 23 and 76).
The immediate precursors of peptidoglycan synthesis are
believed to be bactoprenol-pyrophosphate-linked muropeptides: (Nacetylglucosaminyl-N-acetylmuramyl)-L-Ala-r-D-Glu-L-Xaa-D-Ala-DAla pentapeptide units3. The lipid-linked disaccharide
pentapeptide itself is the end product of a multistep cytoplasmic
and membrane-located biosynthetic pathway. The completed
muropeptide molecules are translocated to the outer face of the
plasma membrane for final peptidoglycan assembly. This step
presumably requires both a glycan chain elongation and an
interpeptide crosslinking machinery, a function which is provided

2

PBP 3 is an exception which is lipid-linked to the membrane
through a cysteinyl residue.

3

Depending on the bacterial species, L-Xaa is a diamino acid
whose w-amino group is either free or substituted by additional
amino acids.
5

by the PBPs (13,23).

(ii) The mechanism of PBP-inhibition by penicillin:

Penicillin

interferes with the "transpeptidase" domain of the PBPs.
Naturally occurring transpeptidation (which is inhibited by
penicillin) is a 2-step reaction (see figure 1, p. 8). First, the
terminal D-Ala-D-Ala peptide bond of the of the precursor is
split through the nucleophilic attack of its carbonyl group by a
conserved serine residue of the enzyme (PBPs are functional
analogs of serine proteases). The terminal D-alanine leaving
group is released to the solvent and an acyl intermediate is
formed between the serine residue of the enzyme and the
penultimate D-Ala residue of the precursor (left panel in figure
1, p. 8 ) . Second, the enzyme is freed by the transfer of the
latter bond to a free amino group (acceptor) in the stem peptide
of the nascent peptidoglycan (not shown in figure 1).
The core of the B-lactam molecule (i.e., the B-lactam ring
plus the C3' residue for penicillins and the C4' residue for
cephalosporins; see generic formula [1]) is a steric analog of
the ubiquitous D-Ala-D-Ala terminal of cell wall precursors
disaccharide-pentapeptides (see left panel in figure 1, p. 8).
[1]
CH

3

c» 3
CH -R'

•C00H

penicillin

cephalosporin

Therefore, penicillin binds to PBPs and undergoes nucleophilic
attack at its C7' carbonyl group in a manner analogous to the DAla-D-Ala of the disaccharide-pentapeptide cell wall precursor
(see figure 1, p. 8 ) . However, because the scissile bond of
penicillin is cyclic, the leaving group of the molecule remains
in place, resulting in the incapacity of the enzyme both to
transfer the bond to an acceptor or to undergo solvolysis (right
panel in figure 1). Therefore, penicillin acts as mechanism-based
(suicide) inhibitor of the enzyme (13,23,43,67).4

The reaction obeys the following kinetics:

_J1_> «<*- k*
[2]

E + D^

? E-D

> ED —

•> E + P

where E is the PBP; D is the B-lactam molecule; E-D is the
Michaelis complex; ED is the penicilloyl acyl enzyme; P is the
reaction product (penicilloic acid); K is the dissociation
constant; and k2 and k3 are the first order rate constants for
acylation and deacylation respectively (13,79). In most PBPs, k2
is big and k3 is small. Therefore, binding of penicillin results
in prolonged inhibition of the enzyme.

4

Since the original proposition of this model by Tipper and
Strominger in 1968 (77), it has gained experimental support and
was recently confirmed by co-crystallization of penicillininteractive proteins with beta-lactam molecules (43,67).
7
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Figure 1: Acylation of penicillin-interactive proteins by either the D-AIa-D-Ala terminal residues of
normal cell wall precursors (A), or penicillin (B). In panel A , R represents the proximal
portion of the precursor (a disaccharide tripeptide, see text) and the dashed lines depict
a virtual molecule of penicillin superimposed onto the D-Ala-D-Ala for comparison. T h e
bottom of panel B shows that after acylation of the enzyme, the leaving group of the P-lactam
molecule is not released to the medium, due to the cyclic nature of the scissile bond. T h e
backbone of the protein represents the active site of the enzyme with the Ser-x-x-Lys
conserved motif followed by an a-helix which helps maintain a positively charged environment
around the carboxyl group of the penicillin molecule.

8

(Hi)

The family of penicillin-interactive enzymes:

As

mentioned above, PBPs belong to a larger (super) family of
penicillin-interactive proteins (23). Among these, another
important membrane-bound protein (BLAR) is a penicillin sensor
which is part of a signal transduction system for the induction
of penicillinase secretion in Bacillus licheniformis (41). Most
of the other members of this family are soluble B-lactamases.
These penicillin-inactivating enzymes are believed to have
evolved divergently from PBPs to specialize in detoxification of
B-lactam molecules (42). The nature of the reaction between Blactamases and penicillin is identical to that shown for the
PBPs, except for the fact that the value of the k3 constant is
much higher. It is thought that B-lactamases have acquired the
ability to hydrolyze the penicilloyl-enzyme bond with H20,
probably by altering the conformation of the enzyme in order to
provide a pocket to accept a water molecule. In the process, they
have lost their transpeptidase activity.
Bacteria (particularly gram-negative organisms) have
engineered a great variety of B-lactamases, which can hydrolyze
virtually all the available B-lactam molecules. Moreover,
antibiotic pressure from new B-lactam derivatives selects for
mutations and remodeling of existing B-lactamases to adapt to the
new antibiotic molecule. The emergence of new B-lactamases (as
extended spectrum B-lactamases) produced by B-lactam resistant
bacteria constitute a major challenge to the chemist involved
with the design of new effective B-lactam compounds.
9

Penicillin-interacting enzymes are classified both by their
functional anatomy (i.e., low molecular weight PBPs; high
molecular weight PBPs; and B-lactamases) and according to their
primary structure. However, divergence in primary structures are
overcome by similarities in the tertiary structure of the
proteins. In fact, all penicillin-interactive proteins contain
four "signature" motifs of amino acids that may be brought within
the enzyme's active center by adequate folding of the
polypeptides. These signatures are (i) a tetrad active site
serine-x-x-lysine (see also figure 1, p. 8 ) , (ii) a triad serine
or lysine-x-asparagine, (iii) a peptide segment (Asp/Glu) that
contains two dicarboxylic amino acids and (iv), a triad lysine,
histidine-threonine or serine-glycine. A detailed discussion of
the biochemical interactions between these residues and the Blactam molecules is beyond the scope of this introduction
(23,40).

III. The journey of the extracellular antibiotic to its membrane
target PBPs

When penicillin is added to a bacterial culture, it has to
cross a variety of chemical and physical barriers before it can
reach and inhibit its specific targets, the membrane-bound PBPs.
The most important physical barrier (in gram-negative bacteria)
is the outer membrane (OM). B-lactams traverse the OM through socalled porin molecules, which provide hydrophilic channels to the
10

periplasmic space. The bacteria can alter both the pore size
and/or the number of the porin molecules, thus interfering with
the access of the antibiotic to the periplasm (28,65). Grampositive bacteria are devoid of OM. However, both gram-positive
and gram negative bacteria may produce poly-anionic
exopolysaccharides which may also hinder the diffusion of
antibiotics to some extent (see 3A). A second obstacle faced by
the antibiotic is the presence of specific B-lactamases secreted or present in the periplasmic space - which may
inactivate the drug before it has reached its targets. As
mentioned above, production of B-lactamases is one of the
powerful mechanisms of resistance found both in gram-negative and
gram-positive bacteria (44,70)5. Eventually, the efficacy of the
drug will depend on its ability to overcome these bacterial
obstacles and to bind to and inactivate its bacterial targets,
the PBPs.
These main steps of the travel of B-lactam molecules to
their targets are also the major variables employed by the
bacteria to modulate their resistance to these drugs. Under
selective antibiotic pressure, bacteria may alter their OM porins
(gram-negative bacteria), produce B-lactamases (qualitatively new
and/or larger quantities) or, reduce the affinity of PBPs for the

s

Sensitivity to B-lactamases can be overcome, to some
extent, by adequate modifications in the B-lactam molecules. This
may result in resistance to hydrolysis by the enzyme or even
inactivation of the B-lactamase. Clavulanic acid and sulbactam
are examples of the latter compounds (44,70).

11

antibiotic. These mechanisms of resistance may arise
independently, but may synergistically coexist in a single
organism. Synergistic resistance is well illustrated by
methicillin resistant Staphylococcus aureus (MRSA), most strains
of which carry both B-lactamases as well as altered (reduced)
affinity PBPs (8,31,53)6.

IV.

Physiological consequences of the inhibition of bacterial

PBPs by penicillin.

(i) Halt of bacterial growth.

The preceding sections have

overviewed the mechanisms by which B-lactam molecules inhibit
specific bacterial targets, the PBPs. Not surprisingly, blockage
of these essential cell wall active enzymes results in inhibition
and/or profound alteration of peptidoglycan synthesis (23,79).
Since bacteria have usually several different types of PBPs, it
6

Shortly after the introduction of penicillin in medicine
(in the early forties), Staphylococcus aureus managed to acquire
a penicillinase-encoding plasmid that rendered these organisms
resistant to this drug. Twenty years later, shortly after the
introduction of the penicillinase-resistant B-lactam methicillin,
methicillin-resistant Staphylococcus aureus (MRSA) arose (31).
This second mechanism of resistance was not mediated by a new
type of B-lactamase, but by the acquisition of a new, additional
PBP (referred to as PBP 2A; (8,53)) with very low binding
affinity for most B-lactam antibiotics. This dual mechanism of
resistance (i.e., production of both B-lactamases and low
affinity PBPs) has transformed these organisms into a public
health hazard. First, there are very few therapeutic alternatives
available to treat severe infections due to MRSA. Second, owing
to their double resistance mechanism, MRSA tend to be selected
among other (less pathogenic) organisms during B-lactam treatment
of unrelated infections.
12

was assumed that each of them might perform complementary tasks,
the coordination of which resulted in the assembly of a "normal"
bacterial sacculus. This assumption was confirmed in E. coli, in
which the function of specific PBPs was inhibited either by
treatment with selectively binding drugs, or by construction of
appropriate mutants. It was observed, for instance, that (i)
inhibition of PBP 1A together with IB of E. coli was lethal
(52B,52C), (ii) inhibition of PBP 2 interfered with elongation
(resulting in spherical cells) (76B) and (iii), inhibition of PBP
3 interfered with septation (resulting in elongated bacterial
filaments)(76B). On the other hand, PBPs 4, 5 and 6 were
apparently dispensable for normal growth under the conditions of
in vitro cultivation (52D,76C). While selective inhibition of one
or the other of the essential PBPs had distinct morphological
consequences, they all had a common eventual result: a halt in
bacterial growth.

(ii) The irreversible effects of B-lactam antibiotics: lysis.
In an original model of "unbalanced growth", it was assumed that
inhibition of transpeptidation (but not transglycosylation) by
penicillin resulted in a weakened cell wall, which eventually was
disrupted by the increased turgor pressure resulting from
the uninhibited increase in the cytoplasmic mass of the bacterium
(i.e., combined osmotic and mechanical pressure - from within).
As an ultimate result of such unbalanced growth, cell wall
integrity was lost, resulting in both lysis and death of the
13

organism. However, this model had to be revised in the light of
two types of later experiments.
First, it was shown that bacterial lysis was mediated by
specific (non-penicillin interactive) peptidoglycan (or murein)
hydrolases (referred to as autolysins) that became deregulated or
"triggered" during treatment of bacteria with B-lactam
antibiotics or other cell wall inhibitors (84). This was
originally demonstrated in pneumococci in which the activity of
the major autolysin was blocked by physiological intervention or
by mutations introduced into the structural gene (lytA) of the
major autolytic enzyme amidase (a N-acetylmuramyl-L-alanine
amidase)(80). When compared to the parent strain (which underwent
rapid and extensive killing and lysis during penicillin
treatment), the lysis defective mutant (Lyt") was not lysed and
was killed more slowly by the antibiotic. This new phenotype, for
which the term "antibiotic tolerance" was coined (80), was not
due to altered PBPs or cell wall structure, but was clearly
related to the suppressed amidase activity.
A second type of experimentation with a tolerant strain of
another bacterium - Streptococcus mutans - suggested that the
irreversible effect of penicillin (i.e., bacterial killing and
cell lysis) resulted from more complicated interactions than
"mere" inhibition of the wall synthesis followed by osmotic
rupture. In these experiments, when bacteria were treated with
high concentrations of penicillin, inhibition of bacterial growth
was paralleled by inhibition of biopolymer synthesis, including
14

peptidoglycan, proteins, RNA and DNA as well (54,63), suggesting
that inhibition of cell wall synthesis actually initiates a
coordinate shutoff (rather than continued unbalanced synthesis)
of most bacterial polymers. It has been proposed that the primary
penicillin targets were only indirectly involved in the
irreversible effect of the drug (84).

(Hi) The bactericidal mechanism(s) of penicillin: In fast-lysing
organisms, such as pneumococci or E. coli, the concurrence of
rapid bacterial lysis and loss of viable cells (i.e., loss of
colony forming units of CFUs) in the culture has led to the
widely-held belief that the cause of penicillin-induced death was
the "suicidal" (unregulated) activity of autolytic enzymes. On
the other hand, it is also known that in certain species of
bacteria, penicillin can have powerful bactericidal activity
without accompanying autolysis (29,34,55). Examples of the
extreme situations are presented in figure 2 (p. 16). On the left
part, wild type Streptococcus pneumoniae is rapidly lysed and
killed by treatment with penicillin. On the right part, S.
sanguis is neither lysed nor killed by the antibiotic. In the
middle, group A Streptococcus is typically resistant to
penicillin-induced lysis, while being highly sensitive to the
cidal effect of the drug. In this latter case bacteria have lost
the ability to divide and form colonies (i.e., lost viability) in
the absence of major physical damage to cell structure.
The notion that penicillin-induced killing of bacteria is a
15
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Figure 2:

Schematic representation of different responses to penicillin treatment in three species
of streptococci (modified from H o m e , D., Tomasz, A. 1977. Antimicrob. Agents and
Chemother. 11:888-896). Growth of the cultures was measured by the increase in
optical density (OD). Penicillin (lOx the M I C ) was added (arrows) to cultures in the
mid-logarithmic phase of growth. Plain lines indicates the O D of untreated control
cultures, dotted lines the O D of penicillin-treated cultures and dashed lines the viable
CFU/ml, as determined by plating aliquots of the cultures on penicillinase-containing
blood-agar plates.
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consequence of osmotic explosion was the logical conclusion of
original experiments with spheroplasts of E. coli K-12 (47).
Penicillin-treated bacteria suspended in an osmotically
protective medium generated stable spheroplasts that could revert
to rod-shaped cells and resume growth after removal of the
antibiotic from the broth. Control bacteria suspended in nonprotective medium lysed and lost viability. Osmotic lysis may
indeed have been the ultimate cause of viability loss in these
particular experiments. However, the interaction between
penicillin and intact bacterial cells is clearly a much more
complicated process. For instance, while ampicillin-induced
spheroplasts of Proteus mirabilis did not lose optical density
over time, viable counts dropped by several log units during
antibiotic treatment (25). In these experiments, the lethal
lesion was likely to be different from the mere osmotic explosion
of the cells.
Another set of intriguing experiments was reported by
Gutmann et al (27). They showed that penicillin-treated cultures
of group A streptococci did not lyse, as measured by the absence
of (i) loss of optical density of the culture, (ii) morphological
damage detectable by electron microscopy and (iii) leakage of
radiolabeled proteins. Yet, rapid loss of viability was observed
when dilutions of the cultures were plated on nutrient blood agar
plates (BAP). However, when plated in parallel on BAP
supplemented with high salt plus sucrose, a substantial
proportion of colony forming units (CFU) could be rescued. This
17

suggested the existence of some minimum, yet lethal, penicillininduced alteration that could be reversed (healed?) by altering
either the ionic strength or the osmolarity of the medium. This
phenomenon remains unexplained, but demonstrates the absence of
major physical damage of the bacteria in this type of penicillininduced bacterial death.

(iv) The non-lytic bacterial death: There are a number of
conditions or agents that decrease bacterial lysis but only
marginally (if at all) reduce cell death. These include, for
instance, treatment of pneumococci with a variety of specific
autolysin inhibitors (57), or overexpression of heat shock
proteins in E. coli (68,95). Moreover, most pneumococcal (88)7
and staphylococcal (Oshida, personal communication) isolates
bearing regulatory mutations in the autolytic system have been
found to be "normally" killed by B-lactam antibiotics, in spite
of the fact that they were only very slowly lysed by the drug.
Even pneumococcal mutants with a completely inactivated amidase
gene (lytA deletion (57,80)) underwent substantial residual
killing, in spite of the absence of cell wall degradation and
lysis during penicillin treatment. Finally, if the major
autolysin amidase was a limiting factor of penicillin-induced
7

Despite of greatly diminished rates of penicillin-induced
lysis, all of 25 penicillin-resistant (MIC > 0.1 ug of
penicillin/ml) clinical isolates of pneumococci were killed in a
similar way as the lysis-prone wild type control strain when
exposed to lOx the MIC of penicillin (data not presented and
(88)).
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killing, lytA mutants should also have emerged from penicillin
selection applied in the laboratory or in the clinical setting
(49,58,81)8. Taken together, these observations suggest that
lysis might not be the primary killing mechanism in these
conditions.

(v) The search for the killing target: Taken together, these
experiments raise the challenge to better define the lethal
lesion inflicted by penicillin to susceptible bacteria. However,
since B-lactam toxicity is a multi-level problem for bacteria,
there might also be several killing targets, which might depend
on both the type of organism and the bacterial environment. For
instance, while penicillin-treated wall-less protoplasts (which
may contain PBPs (48)) can synthesize proteins and increase mass,
they usually cannot divide and give raise to colonies in the
presence of the drug. Moreover, L-forms of bacteria are not
inhibited by B-lactams. These observations indicate that the
toxicity of the drug might not be directly mediated by blockage
of the primary penicillin targets (the PBPs) and suggest that
some insoluble cell wall precursors or metabolites are necessary
for the full-blown effect of the antibiotic (i.e., growth
inhibition and killing). In addition, penicillin-treatment of
tolerant bacteria results in the shutoff of biopolymer synthesis
suggesting that the cells may respond to inhibition of cell wall

8

The lytA gene product (amidase) is dispensable for the
bacterium (81).
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synthesis by a coordinated turn-off of metabolic activities in
the bacterium, the mechanism of which is unknown (54,63).
Finally, penicillin-treatment of gram positive bacteria is also
accompanied by shedding (or secretion) of membrane-bound
molecules such as the lipoteichoic acids, which are also involved
in the regulation of autolytic enzymes in these organisms
(3,67A,82). This may also indicate the existence of antibioticinduced alterations of the plasma membrane during drug treatment
(82). All these different levels must be taken into account in
the search for the cause of bacterial death that is not
accompanied by lysis of the cells.

V. Outline of the thesis

The experiments to be described in the following chapters
are an attempt to define the mechanism(s) of penicillin-induced
killing in Streptococcus pneumoniae. This organism was chosen as
a model for the following reasons. First, wild type pneumococci
are exquisitely sensitive to penicillin-induced killing and
lysis, which places their phenotype at the left extreme of figure
2 (p. 16), corresponding to what is considered as a classical
response to penicillin treatment. Second, in recent years,
clinical isolates of pneumococci have escaped the classic
phenotype to become penicillin-resistant and sometimes also
tolerant to the drug (figure 2 middle and right, p. 16)(49).
Finally mutants which were altered in both their killing and
20

lytic response to penicillin treatment were also isolated in the
laboratory (57,58,80).
In the first chapter, I present physiological and genetic
evidence for the existence of an autolysis-independent mechanism
of penicillin-induced killing in pneumococci. I describe the
identification of a new mutation (cid~), which reduces
penicillin-induced killing in these organisms. The second chapter
describes a series of experiments aimed at cloning the so-called
cid~ determinant. The third chapter is a step-by-step biochemical
and physiological comparison of wild type parents and cid~
mutants of pneumococci, aimed at defining the level at which the
cid~ mutation might operate to provide protection against
penicillin-induced killing. Finally, in the fourth chapter, I
present evidence for a regulated shutoff of RNA and protein
synthesis initiated by inhibition of cell wall assembly during
penicillin treatment of pneumococcal mutants in which the
irreversible effects of the antibiotic are blocked. In this
experimental system I have discovered the production of a unique
72 kD protein, which is specifically labeled by radioactive
cysteine, and which might be part of a regulatory stress-circuit
mediating the global metabolic shutoff and inhibition of growth
in penicillin-treated bacteria.
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Chapter I

Physiological and genetic evidence for the existence of an
autolysis-independent mechanism of penicillin-induced killing in
pneumococci.

Summary of results

In order to clarify the relationship between penicillininduced lysis and killing in pneumococci, we have performed a
series of experiments using both autolysis-inhibiting agents as
well as pneumococcal mutants defective in autolysis (Lyt~) by
virtue of a variety of alterations in the structural determinant
(JytA) of the major autolysin (an W-acetylmuramyl-L-alanine
amidase; referred to as amidase). We also have generated a new
type of mutation (cid~) that drastically reduced penicillininduced killing in both wild-type (Lyt+) and Lyt" mutants of
pneumococci. The cid~ determinant behaved like a single mutation
and was genetically unlinked to the determinant (lytA) of the
major autolysin amidase. However, in Lyt+ cells, the cid~
mutation also reduced the "triggering" of the amidase activity
(i.e., lysis) in addition to protecting the cells from
penicillin-induced killing.
These results suggested the existence of a common,
autolysis-independent pathway to penicillin-induced cell death in
both Lyt+ and Lyt" pneumococci. Moreover, the fact that the cid"
22

mutation reduced both penicillin-killing and lysis (while lytA
mutations decreased principally lysis) also suggested that
penicillin-treated wild-type (Lyt+) pneumococci were first
killed, and then lysed by the drug.
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Materials and Methods

Strains of pneumococci and growth of the organisms.

The

strains of Streptococcus pneumoniae used in these experiments are
described in table 1 (p. 25). Unless otherwise stated, the
microorganisms were grown at 37°C in casein-based semisynthetic
medium at pH 8 (45) supplemented with 0.1% (w/v) yeast extract
(Difco Laboratories, Detroit, MI), which is referred to as C+Y.
In certain experiments pneumococci were grown in the chemically
defined medium Cden (A. Tomasz, Bacteriol. P r o c , p 29, 1964).
Growth of the cultures was monitored by their optical density at
a wave length of 620 nm (0D62O) with a spectrophotometer (SequoiaTurner, Mountainville, CA). Bacterial stocks were frozen in C+Y
containing 10% glycerol and were stored at -70°C.

Antibiotics and reagents. Benzylpenicillin and vancomycin
were obtained from Eli Lilly & Co. (Indianapolis, IN); cefoxitin
and imipenem from Merck Sharp & Dohme (Rahway, NJ); cefadroxil
from Beecham (Bristol, TN); and L-[4,5-3H(N) ]-Lysine (97.4
Ci/mmol) from Dupont NEN (Boston, MA). Antibodies against the
pneumococcal autolysin amidase were prepared as described
previously (15). All other chemicals were reagent grade,
commercially available products.

Susceptibility testing and rate of autolysis and killing of the
microorganisms.

Minimal inhibitory concentrations (MIC) of
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Table 1:

S. pneumoniae strains used in this study

Phenotype
and strain

Lyt A gene

Origin or
reference

Relevant
phenotype
autolytic
status

Killing by
Penicillin

Normal

Lyt +

4-5

Point mutation
Deletion
Plasmid insert.
inactivation

Lyt
Lyt
Lyt

3^
3-4
3-4

Normal

Lyt+

1

this work

Point mutation

Lyt"

1

this work

Plasmid insert.
inactivation

Lyt"

1

this work

Normal

Lyt +

1-2

this work

L y t + (wild type)

R6x
Lyt" mutants
Lyt 4-4

M31
RUP-24
Cid - mutant
Cid-1

see 57
H
t!

M

Lyt" Cid"
Lyt 4-4 x Cid-1
(= strain T6)
RUP-24 x Cid-1
Lyt+ Cid"
recombinants
Lyt" Cid"xR6x

*Loss of log 10 C F U after 6 h of treatment with a 20x M I C of Penicillin
Note that the M I C values of the strains in the Table were similar, i.e., 0.01 jig/ml
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antibiotics for the organisms were determined by the tube
dilution method in C+Y, using 1-ml volumes per tube and 105
CFU/ml as inocula. The MIC was defined as the lowest antibiotic
concentration inhibiting visible bacterial growth after 24 h of
incubation at 37°C. Rates of autolysis were measured in 10-ml
cultures of exponentially growing S. pneumoniae (0D620 = 0.2 to
0.3, corresponding to 0.5 to 1 x 108 CFU/ml) that received
various concentrations of the antibiotics (ranging from lOx to
lOOx the MIC). Control cultures, which were used for the
evaluation of stationary-phase lysis, received no antibiotics.
Autolysis rates were expressed as the first-order rate constant
K, where K - ln(Ao/AX20) x min"1, and where AQ represents the peak
ODeao reading (usually observed shortly after addition of the
drug, see Results section) and A120 represents the reading after a
further 120 min of incubation (49). To determine the effect of
antibiotic treatment on viable counts of bacteria, 100-fil
portions of the cultures were removed after various times of
exposure, serially diluted in semisynthetic medium supplemented
with 1000 U of penicillinase/ml (Becton Dickinson, Cockeysville,
MD), and plated onto tryptic soy agar plates (Difco) containing
3% of defibrinated sheep's blood. The CFU were counted after 36 h
of incubation at 37°C.

Inhibition of pneumococcal autolysis by specific inhibitors of
amidase. Cultures of the lysis-prone (Lyt+) wild-type strain R6x
(see table 1, p. 25) were grown to the early exponential phase
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(about 0.5 x 108 CFU/ml) and treated with the following
autolysin-inhibitory agents: (i) a high concentration of choline
(10 mg/ml) (7,26), (ii) antiserum prepared against the autolysin
amidase (15) (100 /ul of serum per ml) and (iii), trypsin (50)
(100 jug/ml). Incubation continued for an

additional mass

doubling time, when the cultures received 0.1 /ig of penicillin/ml
(i.e., lOx the MIC). The 0D62O and viable titers were then
followed as described above.

Selection of pneumococcal mutants defective in penicillin-induced
killing and lysis.

A nonmutagenized culture of R6x (in 10 ml of

C+Y; see table 1, p. 25) in the exponential phase of growth (1 x
108 CFU/ml) was treated for 4-6 h with 20 x MIC of
benzylpenicillin. The cells were then washed three times by
centrifugation (10,000 g for 10 min) and resuspended in
penicillin-free medium, and the survivors were grown overnight in
fresh C+Y. Such passages were repeated several times and are
referred to as "enrichment cycles". After 18 passages the cells
were again exposed to 20 x MIC of penicillin (cycle 19) for 6 h
and plated for colony count. Nine surviving colonies (all
originating from the same initial culture) were picked at random
from the plates, re-exposed to penicillin (cycle 20), and
designated Cid-1 to Cid-9.

Autolysin specific activity. The autolytic activity in crude
extracts of pneumococci was measured by using a published method
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(33) with slight modifications. In short, exponential-phase
pneumococci were suspended in 500 /xl of ice-cold TMB (0.05 M Tris
maleate buffer at pH 7.0, plus 0.1% of polyoxy-ethylene lauryl
ether) and lysed by sonication for 10 min. The lysates were
centrifuged (12,000 g for 10 min) and the supernatants serially
diluted in TMB. Samples (25 /il) of each dilution were added to
210 /xl of TMB containing 15 ug of cell walls biosynthetically
labeled with radioactive L-[4,5-3H(N) ]-Lysine (3000 cpm/ug of
cell wall) and incubated at 37°C for 30 min. The samples were
then rapidly chilled, and the non-degraded cell wall material was
removed by centrifugation (12,000 g for 10 min). Radioactivity in
the supernatant solution was determined by pipetting 50 /ilportions into 5 ml of Ready-Solv scintillator (Beckman, Palo
Alto, CA) and counting the samples in a Mark II scintillation
spectrometer (Nuclear Chicago, Chicago, IL). Protein
concentrations were determined by the bicinchoninic acid protein
assay (described by Smith et al. (75A) and available in
commercially obtainable kits: Pierce Chemical, Rockford, IL).

Genetic transformation. Chromosomal DNA was prepared by the
method of Marmur (52). Competent pneumococci were prepared by a
previously published method (78). Competent cells (about 0.5 x
108 CFU) were incubated with 0.1 to 1 ug of transforming DNA/ml
at 30°C for 30 min, followed by the addition of DNase (final
concentration, 0.1 /ig/ml) and an expression time of 90 min at
37°C. Transformants were either screened for their lytic response
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to deoxycholate (DOC) using a membrane assay (Millipore Corp.,
Bedford, MA) described previously (16), or selected for their
ability to resist killing by penicillin (Cid~ transformants, see
below) or for resistance to streptomycin.

Transformation of the cid' determinant. High-molecular weight DNA
prepared from a pneumococcal mutant (Cid-1; see table 1, p. 25)
that was highly resistant to the killing effect of penicillin
(Cid"phenotype) was used to transfer the kill resistance marker
(the cidr determinant) into kill-sensitive (Cid+ phenotype)
competent cells with defective or inactivated lytA genes (strains
Lyt 4-4 and RUP-24, Lyt* phenotype; see table 1). As a control,
competent cells were treated with DNA from the lysis-prone and
highly kill-sensitive wild-type strain R6x carrying a
streptomycin resistance (Str) marker (strain R6xStr). Cid'
transformants were selected by two methods, first in liquid
medium and second on agar plates.

(i) Selection in liquid medium. Pneumococcal cultures that
were treated with either Cid-1 or R6xStr DNA were exposed to
consecutive enrichment cycles of treatment with 2Ox the MIC of
penicillin for 6 h, followed by outgrowth of the survivors in
drug-free medium. Such consecutive enrichment cycles select for
Cid" cells (see Results section).
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(ii) Selection on agar plates.

Selection on agar plates was

aimed at the determination of the frequency of transformation of
the cid~ determinant. Ten thousand CFU from cultures treated with
either Cid-1 or R6xStr DNA were plated onto C+Y agar plates (12
ml of 1.5%

C+Y agar plus 250 U of catalase/ml) and were

subsequently overlaid with 8 ml of the same medium and incubated
for 5 h at 37°C, in order to allow each cell to form a microcolony (or miniculture). Then, a solution of penicillin (1 ml of
a 10 /xg/ml preparation) was overlaid and allowed to seep into the
agar, and the incubation was continued for 12 h, after which time
penicillinase (1ml of a 105-U/ml solution) was spread onto the
agar plates, in order to inactivate the antibiotic. Bacteria that
survived penicillin treatment were counted after an additional 48
h of incubation at 37°C.

Statistical analysis. Differences between means were
calculated by the Student t test.
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Results

Effect of autolysis-inhibiting agents on penicillin-induced
killing of pneumococci.

Figure 3 (p. 32) shows that while

inhibitory concentrations of each of the autolysis-inhibiting
agents (i.e., choline, trypsin, or anti-amidase serum) prevented
culture lysis (as measured by the decline in 0D620), there was
virtually no protection from the loss of viability in the
presence of lysis-inhibiting concentrations of choline. Similar
results were also obtained when trypsin or anti-amidase serum
were used in place of choline.

Rate of penicillin-induced killing in pneumococcal mutants
defective in amidase activity.

Cultures of Lyt* mutants Lyt

4-4, M31 and RUP-24 (table 1, p. 25) in the exponential phase of
growth received penicillin (lOx, 20x, or lOOx the MIC), and the
effect of the drug on the 0D62o and the viable titer of the
cultures was followed. None of the mutant cultures showed
significant penicillin-induced lysis, yet substantial loss of
viability continued in all three mutants, albeit at a slower rate
than that of the wild-type (Lyt+) cells. Figure 4 (p. 34) shows
the number of surviving CFU in cultures of isogeneic Lyt+ (R6x)
and Lyt" (RUP-24) strains (table 1) that received lOOx the MIC of
penicillin at a cell concentration of 108 CFU/ml (corresponding
to an 0D620 of 0.25) and were followed for 6 h. The number of
survivors in RUP-24 (Lyt") cultures was 2.8 x 104 + 1.3 x 104
31
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3:

Effect of various specific inhibitors of the autolytic enzyme amidase on penicillininduced lysis (A) and loss of viability (B) of the lysis-prone (Lyt + ) and highly killsensitive wild-type strain R6x. Cultures (10ml) of R6x in the early exponential phase
of growth (about 0.5x 10** CFU/ml) received high concentrations of choline (closed
circles), amidase antiserum (closed squares) or trypsin (open diamonds) and were
incubated for an additional doubling time, when they were treated with lOx the M I C
of penicillin (arrow). Control cultures (open circles) received only penicillin
treatment. The O D 5 2 0 °f ^ e cultures and bacterial survival were followed for 6 h.
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(mean + standard deviation of 19 determinations in three separate
experiments). In comparison, in R6x (Lyt+) cultures the number of
survivors was 2.1 x 103 + 1 x 103 (mean + standard deviation of 17
determinations in three separate experiments), which was
significantly lower than the numbers of survivors in Lyt" cells
(P < 0.001). Similar results were obtained after exposure of the
same isogeneic pair of pneumococci to lOx or 2Ox the MIC of
penicillin or when the Lyt" mutants Lyt 4-4 and M31 were used in
place of RUP-24 (see strains in table 1, p. 25). Thus,
suppression of the major autolysin amidase by either structural
mutations or deletion of the lytA gene resulted in a
statistically significant reduction of penicillin-induced killing
of pneumococci (3 to 4 Log units of killing per 6 h compared with
4 to 5 Log units of killing per 6 h in the parental Lyt+ strain;
P < 0.001). However, loss of viability continued at a
considerable rate in Lyt" mutants (3-4 Log units per 6 h) whether
the lytic defect was due to either a point mutation, insertioninactivation, or a complete deletion of the lytA gene. This
finding shows that the residual killing of Lyt"pneumococci by
penicillin does not involve the autolytic amidase, but some other
as yet undefined mechanism(s).
In order to study such autolysis-independent mechanism(s)
of killing, we have generated pneumococcal mutants with greatly
decreased sensitivity to penicillin-induced killing. These
experiments are described next.
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N u m b e r of surviving C F U of the Lyt + wild-type strain R6x (open circles) and the
Lyt" strain R U P - 2 4 containing an insertionally inactivated amidase (lytA) gene (closed
circles) after 6 h of treatment with lOOx the M I C of penicillin. Cultures (10 ml) of
strains in the exponential phase of growth (10° CFU/ml) were treated with penicillin
for 6 h, and the numbers of surviving C F U were determined. Horizontal dashed lines
represent the mean values of the number of survivors. M e a n +_standard deviations of
the surviving C F U of strain R6x and R U P - 2 4 were statistically different (P < 0.001).
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Selection of pneumococcal mutants with decreased sensitivity to
penicillin-induced killing (Cid") and lysis. Mutants with greatly
decreased susceptibility to penicillin-induced killing (referred
to as Cid" phenotype, for bactericidal) were generated by cyclic
exposure of a penicillin-susceptible, lysis-prone (Lyt+) parental
strain of pneumococcus (strain R6x; table 1, p. 25) to 2Ox the
MIC of penicillin for 4-6 h, followed by removal of the drug and
outgrowth of the culture in antibiotic-free medium (see Materials
and Methods). Such enrichment techniques mimicked the situation
in the clinical setting, where bacteria may be exposed cyclically
to transient high (supra-MIC) concentrations of penicillin
followed by prolonged lower (sub-MIC) levels of the drug.
Colonies surviving the 20th cycle of penicillin treatment showed
a greatly decreased susceptibility to both penicillin-induced
killing and lysis.
Nine independent colonies (Cid-1 to Cid-9, originating from
the same initial culture) isolated in this manner had unchanged
MIC values of penicillin (0.01 /jg/ml) and undiminished
sensitivity to lysis by DOC. On the other hand, each of the nine
mutants showed greatly decreased sensitivity to both penicillininduced killing (loss of viability of 1-2 Log per 4-6 h in the
mutant culture vs. 4-5 Log for the parent strain R6x) and lysis
(K x 103 values, 0.3-1.7 in the mutant cultures vs. 22.0 for the
parent cells; see table 2, p. 37), at both 37°C or 32°C.
Importantly, selection of kill-resistant mutants by cyclic
exposure to penicillin was not a property restricted to the
35

laboratory pneumococcal strain R6x. Cycling of the lytA deletion
or insertion-inactivated mutants M31 and RUP-24 (table 1, p. 25)
or of a penicillin-resistant clinical isolate of pneumococcus
(strain D23, MIC of penicillin 0.12, capsular type 2) also
generated mutants able to survive treatment with high
concentrations of penicillin (data not presented).

Characterization of the kill-resistant and lysis-defective mutant
Cid-1. A single mutant - Cid-1 - was chosen for detailed
studies. The mutant Cid-1 originated from a single (10 ml) nonmutagenized culture of the parent strain R6x, which received the
first penicillin treatment at a cell concentration of 108 CFU/ml,
a result suggesting that the spontaneous frequency for this
mutation was probably greater than 10'9 (this assumption was not
based on experimental result). The kill-resistance and defective
penicillin-induced lysis characterized each of the nine randomly
picked mutants Cid-1 to Cid-9 (see above). However, serial
passage of the mutants in drug-free medium or repeated freezing
and thawing resulted in gradual loss (reversion) of both
phenotypes. This appeared to be due to the overgrowth of the
mutant cultures by revertant cells, which were detectable at a
frequency of about 10~* to 105 in growing cultures and had a
slightly shorter lag phase (compared to the mutant cells) when
regrown from frozen stock into liquid cultures (see Appendix I).
The lysis defect of Cid-1 was not specific for
benzylpenicillin, but was shared by a number of other beta-lactam
36
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antibiotics tested (table 2, p. 37) and also by D-cycloserine, an
antibiotic which inhibits an earlier step of cell wall synthesis
(i.e., the ligation of D-Ala to D-ala which provides the
ubiquitous D-Ala-D-Ala terminus to the precursors of the cell
wall peptidoglycan). Interestingly, two beta-lactam antibiotics
of novel structure,imipenem and CGP 31608 (an investigational
penem antibiotic; CIBA-GEIGY, Basel, Switzerland), and the non
beta-lactam cell-wall inhibitor vancomycin could still lyse and
kill Cid-1, although the rates were slower (ca. lOx) than those
of the parent strain.
Cid-1 contained an autolytic tf-acetylmuramyl-L-alanine
amidase of specific activity equal to that of the parent R6x, as
indicated by identical capacities of crude extracts of both
strains to depolymerize >90% of pneumococcal cell walls labeled
with radioactive lysine (documented in tables 3 and 4, p. 40 and
43 resp.). The normal lysis and >90% cell degradation of Cid-1
treated with DOC (and to some extent with some penem antibiotics
and vancomycin, see table 2) indicated that the cid' mutation did
not cause gross alteration in the structure of the cell wall (see
Chapter III for details).

Genetic characterization of the mutant Cid-1 (Cid" phenotype).
The ability of the Cid" mutants to survive penicillin was first
thought to be the consequence of defective lysis during
antibiotic treatment. However, the continued penicillin-induced
killing of Lyt" mutants completely lacking amidase activity
38

clearly excludes this explanation. The kill resistance observed
in the Cid-1 mutant (illustrated in figure 5, p. 46) must be the
result of some alteration in a second, as yet undefined,
bactericidal target. To better define this second target, we
attempted to characterize the mutation conferring the Cid"
phenotype (provisionally called cid~) at the genetic level. These
experiments are described next.

(i) The lytA gene and the cid' mutation are unlinked genetic
determinants.

Since the Cid-1 mutant was resistant to

penicillin-induced lysis, it was important to determine whether
the cidr was not merely a new lytA allele. To test this
possibility, chromosomal DNA of strain Cid-1 (Cid" Lyt+) was used
to transform RUP-24 (Cid+ Lyt") recipient cells to the Lyt+
phenotype. Transformants were screened and chosen on the basis of
lysis when exposed to DOC. Lyt+ transformants were tested for
penicillin-induced killing and lysis. Note that RUP-24 is
erythromycin-resistant (Erm) due to insertion-inactivation of its
lytA gene with an em determinant (lytA::em genotype; see tables 1
and 3, p. 25 and 40 resp.). Therefore Lyt+ transformants of RUP24 were also expected to be erythromycin-sensitive (ErmS) due to
the conversion of their lytA::em allele by the lytA gene of
Cid-1.
The results are summarized in table 3 (p. 40). As expected,
all 116 independent Lyt+ transformants had lost their Erm marker
along with the transformation to the Lyt+ phenotype. When
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challenged with 20x the MIC of penicillin, all transformants were
also rapidly killed and lysed by the antibiotic, like the wildtype strain R6x (Cid+, Lyt+; see table 3). These results
indicated (i) that the mutant Cid-1 carried a "normalM lytA
determinant that was able to function like a wild-type gene when
transformed back into a Cid+ background, and (ii) that the cidr
determinant was not carried along with the lytA gene in DNA
transformation. Thus, the determinants were genetically unlinked.
This latter observation was further confirmed in the reverse
cross, shown in the next set of experiments.

(ii) Transformation of the cid~ determinant into pneumococcal
recipients lacking the autolysin amidase (Lyt~).

Since both the

cidr and the lytA determinants were genetically unlinked, the
question arose as to whether cidr might also confer the Cid"
phenotype to recipient pneumococci lacking the autolysin amidase.
To answer this question, we attempted to transform kill-sensitive
pneumococcal lytA mutants (Cid+, Lyt") to the Cid" phenotype,
using DNA of the Cid" Lyt+ strain Cid-1. Two methods of selection
were used, one in liquid medium and one on agar plates.

(a) Selection in liquid medium. Cultures of Lyt"
pneumococci sensitive to the killing action of penicillin (i.e.,
Cid+, Lyt" strains) were treated with transforming DNA prepared
from the kill-resistant mutant Cid-1. Such cultures were
quantitatively converted to the Cid" phenotype (1 Log unit
41

killing per 6 h of penicillin treatment) after three to four
enrichment cycles, whereas those treated with the control R6xStr
DNA (rate of transformation to Str 0.1-1%) were still rapidly
killed after six to nine cycles of penicillin treatment (3-4 Log
units of killing per 6 h ) . Table 4 (p. 43) shows the properties
of five such Cid" transformants that were randomly picked from
the plates of two crosses in which either Lyt 4-4 or RUP-24 was
used as the recipient. All the transformants showed the reduced
bactericidal sensitivity of the DNA donor, while they retained
the Lyt" phenotype of the recipients.

(b) Selection on agar plates. Selection on agar plates
allowed an approximate estimation of the frequency of
transformation of the cid~ determinant. In a typical experiment,
11 of 104 (0.1%) CFU treated with Cid-1 DNA survived the
penicillin treatment. Upon testing the bactericidal sensitivity
of these colonies in liquid cultures, 10 of them showed the
typical Cid" phenotype, but none had converted to the Lyt+
phenotype. No survivors were detected among the 104 bacteria
treated with R6xStr DNA (transformation rate to Str of 0.1-1%).
These observations suggested a frequency of transformation of
about 0.1% for the cid~ determinant, which was consistent with
that of a single mutation.
Thus, the cidr determinant could confer resistance to
penicillin-induced killing in either Lyt+ or Lyt" pneumococci and
did not cotransform with the lytA gene. This confirmed our
42
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previous observation that both determinants were genetically
unlinked (see above), and also raised the possibility that cid'
and lytA might be functionally independent.

(iii) Introduction of the lytA gene in Cid" Lyt' transformants.
In order to test whether one marker could affect the
physiological expression of the other, a "wild-type" lytA gene
was reintroduced in a Cid" Lyt" mutant (strain T6) constructed in
the present experiment, and the response of the Lyt+
transformants to penicillin treatment was analyzed.
Table 5 (p. 45) shows the properties of six such Lyt+
transformants. All of them were lysed by DOC and contained normal
(wild-type) levels of amidase activity. However, both their rates
of lysis and killing by penicillin were intermediate between the
values typical of the DNA recipient and the DNA donor strains
(Figure 5, p. 46).
Thus, while the cid~ and lytA determinants are genetically
distinct, there is a functional relationship between both
determinants during penicillin treatment. The cidr mutation is
able to control the rate of penicillin-induced lysis in Lyt+
cells whereas the presence of lytA influences (although
marginally) the rate of killing in Cid" bacteria.
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Figure 5:

Penicillin-induced lysis (A) and loss of viability (B) of the L y t + wild-type strain R 6 x
(open circles), the Lyt" strain R U P - 2 4 containing an insertionally inactivated
amidase gene (closed circles), the kill-resistant mutant Cid-1 (open triangle) and the
Cid" L y t + recombinant (closed triangles). Cultures (10 ml) of the strains in
exponential phase of growth (10** CFU/ml) were treated with 20x the M I C of
penicillin (arrow), and both the O D 5 2 0 ant* bacterial survival were followed for 6 h.
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Discussion

The experimental results described here demonstrate the
existence of two distinct targets or mechanisms for the killing
effect of penicillin (as well as other cell wall inhibitors) in
pneumococci. These two (autolysis-independent and autolysisdependent) targets could be identified by careful quantitation of
the susceptibilities of wild-type pneumococci (Cid+ Lyt+) and two
kinds of autolysin defective pneumococcal mutants (Cid+ Lyt" and
Cid" Lyt" cells), to the bactericidal effect of penicillin. Under
the conditions of our assays (exposure to 20x the MIC of
penicillin for 4-6 h ) , each one of these strains lost viable
titers at characteristic, highly reproducible rates. Wild-type
Cid+ Lyt+ cells lost 4-5 Log units of viable counts per 6 h, Cid+
Lyt" mutants lost 3-4 Log units viable counts per 6 h (a
protection of 1 Log unit that resulted from the inactivation of
the lytA gene), and Cid" Lyt" cells lost 1 Log unit of viable
count per 6 h. Reintroduction of the lytA gene into either Cid+
Lyt" of Cid" Lyt" strains caused an increase in the rate of
killing by approximately 1 Log unit per 6 h. These data indicate
that in the wild-type strains, triggering of the amidase activity
is responsible for about 1 Log unit of viability loss, while the
rest of the killing (3-4 Log units) occurs by a second, amidase
independent mechanism.
This second bactericidal target has been identified in
genetic terms. The cid~ marker is distinct from, the genetic
47

determinant of the autolysin amidase (lytA) and it shows no
genetic linkage to lytA in DNA transformation. Moreover, the
protective effect of the cid~ mutation is fully expressed in
pneumococci completely lacking the amidase.
At this point, it is useful to remember that the autolysin
amidase is dispensable for normal growth of pneumococci both in
vitro and in vivo (in a mouse model of infection) (6,81).
Therefore, if amidase-induced lysis was to be the primary
effector in penicillin-induced killing, one would expect mutants
to arise either in the lytA gene itself, or in its substrate, the
bacterial cell wall. Instead, however, the cid~ mutation appeared
to control another target of penicillin-induced killing which was
operative in both amidase-free (Lyt") and wild-type (Lyt+)
pneumococci. These observations suggest the existence of a common
pathway to cell death during penicillin-induced killing in both
Lyt+ and Lyt" pneumococci. This common pathway is controlled by
cid~, because the mutation can protect both types of cells from
penicillin-induced killing, but not lytA, because inactivation of
this gene only marginally affects penicillin-induced killing.
This suggests that during penicillin treatment, wild-type (Lyt+)
pneumococci are first killed and then lysed by the drug (see
figure 6, p. 50).
While this model determines an order for the physiological
interplay of the cid~ and lytA determinants during penicillininduced killing and lysis of pneumococci, it does not specify the
nature or the number of events involved in the process.
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Experiments aimed at defining the nature of the "killing lesion"
inflicted by penicillin to the cells are presented in Chapter III
of the present thesis dissertation.
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penicillin

20xMIC

cell death

viability:

cell lysis

+/-

+ + +

lytA

cid

Figure 6: M o d e l for the interplay of the cid and lytA genetic determinants in penicillin-induced
killing of pneumococci. T h e bacteria arefirstkilled and then lysed. T h e cid gene (or locus)
controls both penicillin-induced killing Geft plain arrow in die figure) and, to a lesser extend,
lysis by amidase (dotted arrow). T h e lytA gene, in contrast, controls essentially lysis (right
plain arrow), but influences only marginally penicillin-induced killing (see text for details).
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Chapter II

Molecular characterization of the cid~ marker.

Summary of results

This chapter describes several approaches tried to
characterize the cid~ mutation at the molecular level. First we
attempted to generate Cid" mutants by shotgun mutagenesis of Cid+
cells, using either one of the following techniques: (i)
insertion-duplication mutagenesis with a so-called suicide vector
carrying an antibiotic-resistance marker, and (ii) transposon
mutagenesis, using the conjugative transposons Tnl545 or Tn916
(11,73). Second, we attempted to clone the cid~ determinant by a
technique of gene conversion, using E. coli as an intermediate
host.
While both techniques are complementary approaches to gene
cloning, they did not allow the molecular isolation of the cid~
determinant. This suggested the possibility that the nature of
the cid gene was both (i) incompatible with survival of nullmutants (because insertion-inactivated Cid" mutants could not be
constructed) and (ii), potentially toxic for the E. coli
intermediate host (because the cid~ determinant appeared to be
lost during passage through E. coli).
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Materials and Methods.
Bacterial strains and growth conditions.

Five bacterial

strains were used in addition to those used in Chapter I. Strain
E. feacalis BM4110 (Str/Tnl545 [Km, Erm, Tc]; kindly provided by
Dr. Poyart-Salmeron, Institut Pasteur, Paris, France) was used as
a donor in conjugative transfer of Tnl545 to pneumococci (11).
Strain E. feacalis CG110 (Fus, Rif/Tn916 [Tc]; provided by Dr.
Masure from the Rockefeller University, New york) was used in
conjugative transfer of Tn916 (73). Two derivatives of the Lyt"
mutant Lyt 4-4 were used

as recipients in conjugation

experiments, one carrying a Nov marker (to select against the
Tnl545 donor strain) and one carrying an Str marker (to select
against the Tn916 donor).

Finally, E. coli DH5a [in (1)] was

used as an intermediate host for cloning pneumococcal DNA. Unless
otherwise stated, E. feacalis were grown in brain heart infusion
(BHI, Difco) or agar, and E. coli in Luria-Bertani (LB) medium
[in (1)].

Antibiotics and reagents. Erythromycin, tetracycline and
novobiocin were purchased from Sigma Chemical Company (St. Louis,
MO), the restriction enzymes Bell, BamHl, Clal and Taql from New
England Biolabs (Beverly,MA) and EcoRI, Sau3A and T4 ligase from
BRL (Bethesda Research Laboratories Life Technologies, Inc.,
Gaithersburg, MD). All other chemicals were reagent grade
commercially available products.
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Plasmid and DNA preparation.

The plasmid pVA894 (kindly provided

by Dr. Pozzi, University of Sienna, Sienna, Italy; (90)), pJCD9
(9) and pGL80 (14) were used in these experiments. Both pVA894
and pJCD9 are E. coli vectors that cannot replicate autonomously
in pneumococci. However, both vectors contain an Erm marker which
can be expressed in the latter organism, provided that the whole
plasmid is inserted in the pneumococcal chromosome (89). These
vectors were used in insertion-duplication mutagenesis of
pneumococci (see Results section). The plasmid pGL80 is an E.
coli vector that contains an Amp marker as well as the cloned
pneumococcal lytA gene (14).
Large scale plasmid preparations were purified by
differential centrifugation in CsCl and "mini-preparations" by
the rapid alkaline-lysis method [in (1)]. Pneumococcal
chromosomal DNA was prepared by the Marmur method (52).
Restriction enzymes and T4 ligase were used according to the
manufacturers instructions. Ligation of pneumococcal target DNA
fragments in plasmid vectors was performed at molar concentration
ratios of 1/10 (target/vector) without dephosphorylation.
In certain experiments, DNA fragments of specific size
ranges were isolated from chromosomal digests. This was achieved
either by recovery of the fragments after separation by
electrophoresis in low melting point agarose or by fractionation
of partial DNA digests on sucrose density gradients (see next).
For partial digestion, 1000 jug of chromosomal DNA from the
Cid' mutant Cid-1 (table 1, p. 25) in TE (20 mM Tris HC1 pH8 and
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5 mM of EDTA) plus adequate amounts of restriction enzyme buffer
were distributed in 9 Eppendorf tubes (450 /il in tube #1 and 250
/il in the remaining tubes). Fifty /il of a solution containing 250
U of the appropriate restriction enzyme were added in tube #1 and
2x-serially diluted over the other tubes, except for tube #9,
which received no enzyme. Digestion was allowed for 1 h at 37°C
and stopped by heat inactivation of the enzyme for 20 min at
57°C. The quality of the digest was controlled by agarose gel
electrophoresis.
For size separation by sucrose gradient density, the DNA of
the 9 tubes was pooled and overlaid on a 10-40% sucrose gradient
(in 35 ml of 1 M NaCl, 20 mM Tris HC1 pH8 and 5 mM of EDTA)
contained in SW28 tubes. After centrifugation for 20 h at 24,000
rpm (at 20°C) fractions of about 1 ml were collected. The
fractions were tested both for appropriate size separation by
agarose gel electrophoresis and for their ability to transform
the Cid" phenotype to Cid+ pneumococci (using penicillin cycling,
see Chapter I). DNA fragments from suitable fractions were
dialyzed in TE and concentrated by ethanol precipitation before
being used for ligation in E. coli vectors.

Conjugation and DNA transformation. Conjugative transfer of
Tnl545 and Tn926 was performed by slight modifications of the
filter mating method (11,73). Liquid cultures of both donor and
recipient strains were grown to late logarithmic phase (0D620 of
0.6-0.7), mixed at a ratio of 1/10 (1 ml of the donor culture for
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9 ml of the recipient culture) centrifuged, suspended in 200 /il
of fresh BHI broth and spread on Millipore filters (0.45 /ig) on
top of BHI agar plates supplemented with 3% of defibrinated sheep
blood. The diameters of the filters were 25 mm and 45 mm in
experiments with Tnl545 and Tn926 respectively. After 16 to 20 h
of incubation at 37°C, pneumococcal transconjugants were selected
by either of the following techniques, (i) For Tnl545, the
bacteria were washed from the filters with

2 ml of medium, and

plated on BHI agar supplemented with 10 ug of novobiocin/ml (to
select against the donor strains) and 1 ug of erythromycin/ml (to
select for the transposon). (ii) For Tn916, the filters were
replica plated on blood agar plates containing 100 ug of
streptomycin/ml (to select against the donor) and 10 ug of
tetracycline/ml (to select for the transposon). This latter
technique permitted to isolate the progeny of independent
pneumococcal transconjugants.
DNA transformation in pneumococci was as described in
Chapter I. Inducible erythromycin resistance was selected using a
"sandwich" plating technique. Petri dishes containing a first 8
ml agar layer were overlaid with a second 8 ml layer of blood
agar containing adequate dilutions of the transformed bacteria.
Expression of transformed genes was allowed for 90 min at 37°C,
after which a new 8 ml of agar (buffer layer) was poured, allowed
to solidify and overlaid by a last 8 ml of agar containing 3 ug
of erythromycin/ml. The plates were then incubated for 24-48 h at
37°C before erythromycin resistant transformants were counted.
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To transform E. coli DH5a, 50 /il of an overnight culture in
LB broth were inoculated in 5 ml of fresh medium, grown for 3 h
at 30°C in a shaking incubator, chilled on ice, pelleted and
suspended in 75 /il of fresh prechilled LB broth. After 5 min on
ice, the cells were gently mixed with and additional 75 /il of socalled 2x-TSS (see below) and left 5 more min on ice before DNA
was added. Incubation with DNA on ice was allowed for another 30
to 60 min, before a 2 min heat shock (42°C) was applied followed
by rapid chilling and addition of 1 ml of fresh LB broth to the
tubes. A 90 min expression time at 37°C in a shaking incubator
was allowed before plating the cells on selective media.
(Composition of 2x-TSS [Transformation and Storage
Solution]:

0.8 g of tryptone, 0.5 g of yeast extract, 0.5 g

of NaCl, 20 g of polyethylene glycol 8000, 10 ml of
dimethylsulfoxide and 10 ml of 1M MgS04-7H20, dissolve in 80 ml
of water, adjust pH at approximately 6.5, autoclave and store at
4°C).
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Results

I.

Shotgun mutagenesis

1.1. Attempt to generate Cid" mutants by shotgun insertionduplication mutagenesis. The general technique is illustrated in
figure 7 (p. 58). Two so-called suicide vectors (pVA891 and
pJCD9; (9,90)) were used. Both vectors carry an erythromycinresistance (Erm) marker, but are unable to replicate autonomously
in S. pneumoniae. However, Erm can be expressed in pneumococci,
provided that the whole vector gets inserted in the bacterial
chromosome.

By themselves, the vectors cannot insert into the

pneumococcal chromosome, because they lack homologous DNA.
However, if fragments of pneumococcal DNA are ligated in the
suicide vectors, the recombinant plasmids can successfully insert
into the pneumococcal chromosome by single cross-over (Campbelllike) at the site of the homologous DNA insert (see figure 7, p.
58 and reference (89)). It is this latter property that underlies
the technique of insertion-duplication mutagenesis. Only
transformants with chromosomal inserts express Erm.
Potential draw-backs of the technique are also evident from
figure 7. First, if the chromosomal fragment in the vector
encompasses a whole gene, gene duplication (instead of insertioninactivation) will occur. Second, if the insert contains only one
end of the gene, partial duplication will restore a whole copy of
the gene on one side of the insertion, but not result in gene
57
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Figure 7: The technique of insertion-duplication mutagenesis. The homologous D N A fragments
ligated to the heterologous plasmid must be an internal segment of the target gene
for successful gene inactivation. Larger fragments m a y result either in gene duplication
(if the fragment encompasses the whole gene) or in restoration of one copy of the gene
(if the fragment encompasses only one end of the target gene; see text for details).
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inactivation. To avoid these problems, it is critical to digest
the target DNA with restriction enzymes yielding fragments
smaller than the length of an average gene (i.e., less than 1
Kb).
This was achieved by digesting chromosomal DNA of the Cid"
mutant Cid-1 with either of the two four base-pairs cutting
enzymes Sau3A and Tagl. Cid-1 chromosome digested in this way had
lost the ability to transform the cid~ determinant into Cid+
recipient cells, whereas undigested high molecular weight control
DNA retained this capacity (data not shown). The 5au3A (resp.
Tagl) chromosomal digests were ligated to the BamHl (resp. Clal)
sites of either of the vectors, and the ligations were used to
transform competent cells of the Cid+ Lyt" mutant Lyt 4-4.
Transformants were selected for Erm (using the "sandwich"
method), pooled and submitted to enrichment cycles of penicillin
exposure (as described) in order to select for potential Cid"
mutants. In each experiment, a positive control consisting of Lyt
4-4 transformed with high molecular weight DNA of Cid" cells was
included.
In one experiment, an internal control was run to test the
ability of the mutagenesis method to generate auxotrophies (using
pVA891 ligated to a Sau3A chromosomal digest). After selection
for Erm, 1000 independent transformants were tested for
auxotrophy to yeast extract, by streaking each one of the
colonies on Cden agar plates supplemented or not with 0.1% (w/v)
of yeast extract. Yeast extract auxotrophy was chosen because it
59

appeared to be a characteristic of the mutant Cid-1 (see Appendix
I).
Eleven out of 1000 (1%) auxotrophies to yeast extract were
detected. All of them were stable, but grew slowly on rich media
and were not further characterized. However, they probably had
resulted from gene disruption and indicated that the method of
mutagenesis worked.
The results of selection for Cid" insertion-inactivated
mutants are summarized in table 6 (p. 61). It can be seen that no
Cid" mutants could be selected out of 19,000 independent
transformants that had received an insertion of the Erm marker in
their chromosome. As a control, cultures of the Cid+ Lyt" strain
Lyt 4-4 treated with high molecular weight chromosomal DNA of the
Cid" donor Cid-1 had converted to the Cid" phenotype after only
three cycles of penicillin treatment. Competent Lyt 4-4 cells
transformed with closed-circular forms of either plasmids pVA891
or pJCD9 alone did not yield any Erm transformant at all.
These results suggested that either the cid" determinant
could not be thoroughly inactivated (because null-mutants might
not be viable), or that the technique of insertion-duplication
mutagenesis was inappropriate to inactivate cid, in spite of the
fact that two different four base-pairs cutting enzymes (Sau3A
and Tagl) had been used and that auxotrophies could be obtained
with the technique. This latter possibility led us to repeat the
shotgun mutation experiment using the conjugative transposons
Tn2545 and Tr\916.
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1.2

Shotgun mutation by transposon mutagenesis.

Conjugation was

carried out by the filter mating method using the donor strain E.
feacalis BM4110 for Tnl545 and E. feacalis CG110 for Tn916 (see
Materials and Methods). Experiments with Tnl545 were not pursued,
because the frequency of transconjugant was too low (10~7-10~8 per
recipient cell). In contrast, experiments with Tn92t5, had a good
yield (10"3-10-4) and were carried on. About 10,000 Tn926
pneumococcal transconjugants were pooled and subjected to cycling
with penicillin. Again, the cycling technique failed to select
for Cid" Tn916 transconjugants. In contrast, Lyt 4-4 cells (Cid+
Lyt") treated with the control high molecular weight DNA of Cid-1
converted to the Cid" phenotype within only a few cycles of
penicillin treatment. Thus, shotgun mutagenesis using Tn916 also
failed to generate Cid" mutants.

II. Attempt to clone the cid" determinant by the technique of
gene conversion.

II.1. Experimental design. The experiment consisted of
screening an E. coli library of pneumococcal DNA fragments
containing the cid~ determinant (in the plasmid vector pJCD9) for
its ability to transform (by gene conversion, see figure 8, p.
64) Cid+ pneumococci to the Cid" phenotype. The advantage of the
technique is that (i) it does not inactivate the target gene (as
in insertion-inactivation mutagenesis) and

(ii), it can detect

both dominant as well as recessive genes, because only one allele
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is expressed at a time.
Figure 8 (p. 64) depicts the three major steps of the
experimental design. First Cid-1 chromosomal DNA was digested
with appropriate restriction enzymes and the smallest fragments
containing the cid~ transforming activity were isolated. Second,
"mini-libraries" of these fragments were created in E. coli,
using the cloning vector pJCD9 (9). This plasmid contains a lacZ
polycloning site flanked by two transcription terminators, which
help stabilize DNA inserts containing strong promoters, a problem
that may arise when cloning pneumococcal DNA. Third, the "minilibraries" of recombinant pJCD9 plasmids were transformed back in
Cid+ pneumococci and screened for their ability to transform the
cid~ determinant.
Note that the genetic recombination event expected here was
a double cross-over, resulting both in conversion of the target
gene and loss of the plasmid vector (see also Appendix II). This
was in contrast with the technique of insertion-duplication
described above (see figure 7, p. 58), in which single cross-over
(Campbell-like) resulted in insertion of the plasmid and
duplication of the target DNA. To promote gene conversion, DNA
fragments larger than a gene (>1 Kb, resulting from digestion
with 6 base-pairs cutting restriction enzymes) were ligated to
the plasmid vector. In these conditions, double cross-over occurs
>100x more often than single cross-over (see Pozzi et al (69) and
the control experiment in Appendix II).
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Figure 8: Experimental design used to clone the cid- determinant by the technique
of gene conversion (see test for details).
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II.2

Screening for the smallest Cid-1 DNA fragments

containing the cidr transforming activity.

Complete digestion

of Cid-1 chromosomal DNA with either Ecorl, Bell or Kpnl did not
destroy the transforming activity of the cid~ determinant. These
chromosomal digests were submitted to separation by
electrophoresis on low-melting point agarose. Gel slices
containing different size ranges of DNA fragments were cut,
melted and used to transform Cid+ Lyt" (Lyt 4-4) recipient cells
to the Cid" phenotype. The Bell digest yielded the smallest DNA
fragments still containing cidr transforming activity (2-4-Kb),
followed by Ecorl (6-10 Kb) and Kpnl (15-20 Kb). Therefore, Bell
was the enzyme used to digest Cid-1 DNA in further experiments.
A large scale preparation of Bell fragments was obtained by
(partial) digestion of 1000 /Lig of Cid-1 chromosomal DNA with the
enzyme, followed by fractionation of the fragments on a sucrose
gradient as described in Materials and Methods. The fraction
containing the smallest DNA fragments able to transform the Cid"
marker (fraction # 17, 2-6 Kb DNA fragments) was used in the next
set of experiments.

C. E. coli "mini-libraries" of Cid" DNA followed by backcross
into Cid+ recipient cells.

Fraction 17 was ligated to the

BamHl site of pJCD9 and transformed in E. coli DH5a.
Transformants were selected for the vector marker Erm (1000
pg/ml) and screened for white colonies (containing DNA inserts)
on LB-agar plates supplemented with XGal. Two thousand and four
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hundred independent Erm and white transformants were isolated,
grown separately in tubes containing 2 ml of LB broth
supplemented with 500 /xg of erythromycin/ml, and pooled in socalled "mini-libraries" of 50-70 colonies before plasmid DNA was
extracted. Heterogeneity of the plasmid sizes was controlled by
agarose gel electrophoresis. These "mini-libraries" containing
the putative cid~ gene were then transformed in the Cid+ Lyt"
pneumococcal recipient Lyt 4-4. Selection was not for Erm, (which
would have accounted for insertion of the plasmid, as described
above), but for the Cid" phenotype, by cycling with penicillin.
A positive control tube received high molecular weight DNA
of the Cid" mutant Cid-1, and a negative control received DNA of
the wild-type Cid+ Lyt+ strain R6xStr carrying a streptomycinresistant marker to account for the overall frequency of
transformation (which was 0.1-1%). In addition, in certain
experiments, an internal control was run by subculturing aliquots
of transformed cells on erythromycin-containing plates to test
for the ability of the recombinant plasmids to insert into the
chromosome by single cross-over (see above). Such Erm
transformants occurred at a frequency of 0.01%, demonstrating
that passage through E. coli was not incompatible with DNA
processing by pneumococci.
The results are summarized in table 7 (p. 67). While high
molecular weight DNA of the mutant Cid-1 as well as the Bell
digest fraction 17 (used as target fragments to clone in pJCD9),
transformed Cid+ recipient cells to the Cid" phenotype, neither
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Table 7:

Testing E. coli "mini-libraries" of Cid-1 D N A for
transformation of the Cid" phenotype.

Penicillin cycling
number of cycles to
select Cid"

total numbers of
cycles

cor version to
Cid" phenotype

> 8

3-4
4-5

8
8
8

No
Yes
Yes

#1
#2
#3

> 8
> 8
> 8

8
8
8

No
No
No

#14

> 8

Source of D N A

R6x chromosome
Cid-1 chromosome
Bel 1 Fract 17
§" Mini-libraries"

No

§ = fraction 17 of sucrose density gradient of Cid-1 x Bel 1 digest.
( see text for details )
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of the 14 "mini-libraries" succeeded in converting Cid+ cultures
to the Cid" phenotype.
Thus, cloning of the cid" marker using E. coli DH5a as an
intermediate host did not succeed, in spite of the fact that (i)
successful gene conversion could be achieved in pneumococci with
the experimental system described (see Appendix II), (ii) the
Bell pneumococcal fragments ligated to pJCD9 transformed the cid~
determinant into pneumococci, (iii) adequate quality and
quantities of the "mini-libraries" DNA were used to transform
pneumococci (as shown by the internal control described above)
and (iv), theoretically enough Erm LacZ" E. coli recombinants
were picked to assure the adequate representation of all the Bell
pneumococcal fragments present in fraction 17.
These results raised the possibility that the cid' marker
might have been lost during passage through the E. coli host,
either because it was incompatible with plasmid maintenance, or
because its product was toxic to the cells.
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Discussion

The selection for Cid" mutants by gene insertion
inactivation mutagenesis did not fail for trivial reasons. Both
techniques of mutagenesis described above have been successfully
used to interrupt several genes both in pneumococci and other
streptococcal strains (59,91). For instance, insertionduplication mutagenesis was used by Morrison et al. (59) and
Masure et al. (personal communication) to interrupt and clone
pneumococcal genes involved in competence. In both cases,
pneumococcal chromosome was digested with the 4 base-pair cutting
enzyme Sau3A before being ligated in adequate vectors and
transformed back into pneumococcal recipient cells. Effective
inactivation of target genes (affecting competence) were found in
about 1/1000 insertion-transformants. Considering that competence
involves probably > 10 genes (up to 30 proteins seem to be
involved in the whole process of transformation; (59)) their
chance to target one specific gene was not more than 1/10,000
insertions. In our experiments, we used two types of 4 base-pair
cutting enzymes (Sau3A and Tagl) and obtained 1/100 auxotrophies
to yeast extract. This relatively high number of hits (as
compared to 1/1000 in Morrison's experiments) might have several
explanations, including the possibility of redundant insertions
in the same gene and/or the fact that yeast extract auxotrophy
might involve many more genes than competence. However, the
results of this control experiment showed that the technique
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worked, and the absence Cid" mutants among the 19,000 insertiontransformants screened (10-20x more than Morrison et al. or
Masure) arose the possibility that either (i) mutants with
insertion-inactivated cid gene were not viable or (ii), the cid
gene could not be inactivated because it did not have two
internal restriction sites for the enzymes used (see figure 7, p.
58).
The failure to obtain Cid" mutants using Tn916 insertion
mutagenesis is an argument for the former possibility. Tn916 has
been successfully used to interrupt genes in both pneumococci and
group B streptococci (73,91). On the other hand, insertion of
Tn926 might not be perfectly random in pneumococci, because its
mechanism of insertion involves a circular intermediate with an
AT-rich repeat around the insertion site (10), which might affect
the randomness of insertion into AT-rich target DNA (such as the
pneumococcal chromosome). Therefore, as with insertionduplication mutagenesis, one cannot formally exclude that the
failure to select for insertion-inactivated Cid" mutants was not
due to the lack of correct hit by Tn916.
However, the number of negative experiments and the fact
that both techniques had been successful in interrupting genes
other than cid are indirect arguments for the fact that null-cid
mutants might not be viable. An instructive precedent for such a
hypothesis is that transposon-mutagenesis also failed to yield
Cid" mutants in Staphylococcus aureus (Oshida personal
communication). In these experiments, a Cid+ staphylococcal
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strain was mutagenized with Tn551. This transposon has been
successful in interrupting a number of genes related to
methicillin-resistance, including the gene of the penicillin
binding protein 2A (PBP 2A) and several so-called auxiliary genes
responsible of the control of peptidoglycan synthesis (5,53,62).
When libraries of Tn552-insertion mutants of staphylococci were
cycled with high concentrations of methicillin, Cid" derivatives
arose, as in pneumococci. However, the Cid" phenotype did not
cotransform with the transposon in backcross experiments,
indicating that the Cid" phenotype was not due to the transposon,
but to another (spontaneous) mutation located elsewhere in the
chromosome. Thus, as in pneumococci, null mutants in the ncidn
determinant might not be viable in staphylococci.
For this reason, we attempted to clone the cid" determinant
by gene conversion. Control experiments in which the

lytA::em of

RUP-24 was converted to lytA by the E. coli plasmid pGL80
(containing the cloned pneumococcal lytA gene) confirmed that the
experimental design was appropriate (see Appendix II). In
addition, the E. coli cloning vector (pJCD9, (9)) used to expand
pneumococcal DNA beared two transcription terminators flanking
the cloning site, to decrease the risk of instability of
recombinant plasmids containing DNA inserts with strong
promoters. In spite of these precautions, the cidr transforming
activity was lost during passage through E. coli. This was
unlikely to be due to a trivial misrepresentation of the correct
DNA fragment in the library, since the library had been enriched
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in DNA fragments containing the cid~ marker and care had been
taken to collect a large number of recombinant clones (2400). In
addition, each recombinant clone had been grown separately to
turbidity before being pooled for plasmid extraction. Thus, the
most likely explanation was that the plasmid containing the cid"
determinant could not be maintained in E. coli.
The frequency of E. coli "persisters" (i.e., survivors)
during ampicillin treatment has been shown to be under the
control of a gene called hypA (for high ampicillin persisters),
which has been cloned (60,61,75). The gene encodes for a ca.
50,000 kD protein that might be involved in the regulation of
cell division. Most interestingly, hypA could not be maintained
in a plasmid under the control of a strong promoter, presumably
because its product is toxic for the cell (61). If cid" performs
some equivalent function to hipA, it is conceivable that cloning
the cid" determinant in a multicopy plasmid might also result in
toxicity for E. coli. Whether cid" is the pneumococcal equivalent
of hypA is not known. However, both Cid" and HipA phenotypes
share the ability to reduce killing due to inhibition of either
cell wall synthesis (beta-lactams) or DNA replication
(quinolones; cid" decreased temofloxacin-induced killing by ca.
lOOx in pneumococci, data not presented).
As envisioned above, it is possible that the cid determinant
is a gene that performs some vital function that can neither be
completely eliminated from the cell, nor overexpressed. The
appearance of a new nutritional requirement - genetically
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inseparable from the cid locus - is also consistent with this
notion (see Appendix I). Moreover, since cid", as hypA, appears
to control cell death due to both inhibition of cell wall
synthesis and DNA replication (two events that are synchronized
with cell division; (32)), it is possible that the cid product
might be directly of indirectly involved in the regulation of
cell division, as has been suggested for the hypA determinant of
E. coli (75).
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Chapter III

Studies on the biochemistry and physiology of cell wall
degradation in Cid+ and Cid" pneumococci.

Summary of results

The experiments presented in the first chapter have
suggested the existence of (at least) two consecutive events
during penicillin-induced killing and lysis of pneumococci: first
killing and second lysis. It was shown that killing and lysis
were formally separate phenomena that could be dissociated in
both physiological experiments (during penicillin treatment of
Lyt+ and Lyt" mutants) and in genetic crosses, because killing
and lysis could be affected separately by independent mutations
(resulting in Cid" and/or Lyt" phenotypes). However, while the
major mechanism(s) of penicillin-induced killing of pneumococci
appeared to be autolysis-independent, neither the nature of the
lethal event, nor the mechanism of protection afforded by the
cid" mutation against penicillin-induced killing and lysis were
specified. Therefore, it was important to run complementary
biochemical and physiological experiments, in order to better
define both the cellular localization of the major (autolyticindependent) killing event and the mechanism of protection
afforded by the cid" mutation.
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Figure 9 (p. 76) depicts the principal known penicillin
targets of the cells. The primary targets are the membrane-bound
penicillin-binding proteins (PBP), which are "irreversibly"
acylated and inactivated by the antibiotic. The secondary targets
are the autolytic enzymes and their substrate, the bacterial cell
wall peptidoglycan, which are responsible for cell wall
degradation and bacterial lysis during penicillin treatment.
Additional molecules also known to influence bacterial autolysis
and present in these structures are depicted in figure 9: they
include the cell wall-bound teichoic acids and the membrane-bound
lipoteichoic acids (20,82).
In order to detect potential differences between these
cellular structures in Cid+ and Cid" cells, we have run a step by
step biochemical analysis of some specific properties of these
penicillin targets in both types of bacteria. In addition,
physiological experiments have allowed us to more accurately
define the cellular level at which the cid" mutation might
operate to protect pneumococci from penicillin-induced killing.
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Figure 9:

T h e cartoon depicts the most c o m m o n primary and secondary penicillin targets
of pneumococci. P B P = penicillin-binding proteins (primary targets); A = autolysins
(secondary targets); L T A = lipoteichoic acids (involved in the regulation of autolysis);
T A = cell wall teichoic acids (absolutely required for the activity of amidase in
peumococci).
|
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Materials and Methods

Titration of the penicillin-binding proteins (PBPs).
Exponential-phase microorganisms (1 ml; ca. 8 x 107 cells/ml)
were incubated with [3H]-benzylpenicillin at concentrations
ranging from 0.3 to lOx the MIC at 37°C for 10 min.

An excess of

unlabeled benzylpenicillin (1.7 mM) was then added, and the
samples were immediately chilled on ice.

The bacteria were

recovered by centrifugation (12,000 x g for 5 min at 4°C),
suspended in 50 /il of 0.05 M sodium phosphate buffer (pH 7.0)
containing 1.7 mM of unlabeled benzylpenicillin and 1% Sarkosyl
NL-97 (Sigma), and incubated for 5 min at 37°C. This treatment
resulted in complete lysis of the microorganisms and inactivation
of the PBPs.

The lysates were then prepared for SDS-PAGE.

The

techniques used for discontinuous gel electrophoresis, staining,
and detection of the PBPs by fluorography have been described
earlier (93).

Cell wall preparation. Pneumococcal cell walls were prepared by
a published procedure (18,20). In brief, exponentially growing
cultures were rapidly chilled by immersing the flasks in an
ethanol-ice bath until the temperature reached 4 to 0°C. After
the cells were harvested by centrifugation at 4°C, they were
suspended in iced phosphate-buffered saline and quickly dropped
into boiling SDS (4% final concentration) to inactivate any
wall-modifying enzymes.
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Walls were mechanically broken by

shaking with acid-washed glass beads in a Vortex mixer operating
at top speed.

It took about ten 1-min pulses to disrupt over 90%

of the microscopically identifiable bacterial forms.

Unbroken

cells and glass debris were sedimented by low-speed
centrifugation (5,000 x g, 10 min).

Cell wall fragments were

pelleted at 25,000 x g, suspended in buffered saline with 0.05%
sodium azide, and digested with DNase, RNase, and protease as
described, except that proteinase K was substituted for trypsin.
Peptides from protease digestion and remaining lipids were
extracted with boiling 1% SDS, and the wall fragments were washed
twice with water and incubated for 15 min at 37°C, first with 8 M
LiCl and then with 100 mM EDTA, to remove material bound by ionic
interactions.

After another water wash the fragments were

treated with acetone, suspended in water, and lyophilized.
To introduce a radioactive label into the cell walls, one of
the following methods was used.

(i) For [3H]-lysine labeled

walls, bacteria were grown for 2 h in the chemically defined
medium Cden containing L-[4,5-3H(N)]-lysine (New England Nuclear
Corp., Boston, MA) at a final concentration of 5 uCi and 10
/ig/ml.

(ii) For [3H]-choline labeled walls, bacteria were grown

in the semi-synthetic medium C+Y, to which [methyl-3H]-choline
chloride (New England Nuclear Corp.) was added at a final
concentration of 1 uCi or approximately 15 ng/ml.
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Preparation of cell extracts and measurement of their cell
wall-hydrolyzing capacities.

(i) For extracts of Lyt* pneumococci'. 10 ml cultures (in C+Y)
were grown to an 0D62O of 0.7, chilled, harvested by
centrifugation, washed and resuspended in 500 /il of 50 mM Tris
maleate buffer at pH 7 + 0.1% (v/v) of the detergent Brij 35.
The cells were lysed by the addition of 0.1% of DOC (w/v, final
concentration) followed by incubation for 10 min at 37°C. The
lysates were then chilled and "cleared" by centrifugation for 5
min at 10,000 x g (at 4°C). Protein concentration was determined
in the supernatant (using the bicinchoninic method (75A)) and the
samples were frozen at -70°C.
To compare the cell wall-hydrolyzing capacity of the
extracts, 400 /xg (in 200 /il of buffer) of proteins were 2xserially diluted in 8 tubes (from 1/1 to 1/128 plus one negative
control) and 25 /il of each dilution (plus the control) was
transferred to a series of tubes containing 155 /il of the same
buffer + 20 /il of [3H]-lysine labeled pneumococcal cell walls
(specific activity 3 x 105 cpm; 660 /ig/ml). The tubes were
incubated for 30 min at 37°C, after which time the reaction was
stopped by rapid chilling and addition of 25 /il of formaldehyde
and 25 /il of 1% bovine serum albumin.

After centrifugation for

10 min at 10,000 x g, the radioactivity that was released to the
supernatant was measured by liquid scintillation counting.
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(ii) For Lyt~ pneumococci: Extracts of pneumococci from which
the genetic determinant of the major autolysin (amidase) was
deleted contained another enzymatic activity capable of a slow
hydrolysis of cell walls (17,74).

To prepare enzyme extracts

from Lyt" cells, bacterial cultures (1 liter) were harvested in
the middle of the exponential growth phase (about 0.5-1 x 108
CFU/ml).

Pellets were suspended in 5 ml of 10 mM Tris

hydrochloride (pH 6.8) containing 10 mM MgCl2 and DNase I and
RNase I, each at 100 /ig/ml; the suspension was mixed with an
equal volume of glass beads (diameter, 100 /im; Thomas Scientific,
Swedesboro, NJ) and stirred vigorously by vortexing (Scientific
Industries Inc., Bohemia, NY) at 4°C for 10 to 15 min.

The

detergent Brij 35 and a LiCl solution were added to give 0.1% and
1.0 M final concentrations, respectively.

The debris of broken

cells and glass beads was removed by centrifugation (10,000 x g
for 10 min), and the supernatant was further clarified by
ultracentrifugation at 40,000 x g for 1 h.

The supernatant was

then dialyzed overnight at 4°C against 10 mM Tris hydrochloride
(pH 7.0) containing 0.1% Brij 35, and small batches containing
1.0 mg of protein per ml were stored frozen at -70°C.
The enzymatic activity in these extracts was determined as
follows.

A total of 50 /il of enzyme extract (protein

concentration 1 mg/ml) was mixed with 90 /il of buffer (10 mM Tris
hydrochloride [pH 6.8]), 10 /il of Brij 35 (5% solution), and 20
/il of [3H]-lysine-labeled cell walls, and the suspension was
incubated for several hours at either 30 or 37°C.

80

The reaction

was stopped and the radioactivity that was released to the
supernatant was measured as described above.

For the removal of

cell wall teichoic acids, cell walls (3.6 mg) were suspended in 2
ml of 49% hydrofluoric acid (HF), and the suspension was stirred
slowly at 0°C for 24 h.

The HF was removed by centrifugation of

the cell walls and extensive washing of the pellet with distilled
water.

The pellet (cell wall peptidoglycan free of teichoic

acid) was dried (recovery, 1.6 mg) and subsequently suspended in
distilled water and stored at -20°C.

This treatment

quantitatively removed teichoic acid components of the cell wall,
as indicated by chemical analysis for galactosamine, phosphorus,
and choline.

Cell wall hydrolysis by purified amidase. Purified amidase was
prepared by a previously described method (20) from cultures of
the E. coli strain CM21 (14) containing the cloned pneumococcal
lytA gene in the plasmid pGL80. One unit of amidase activity was
defined as the amount of enzyme capable of digesting 1 ug of cell
wall in 10 min). Susceptibility of various cell wall preparations
to hydrolysis by purified amidase in vitro was titrated by a
dilution method similar to that described for Lyt+ cell crude
extracts (see above), except that purified amidase was used as an
enzyme and various [3H]-choline labeled cell walls were used as
substrates (see Results section).
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Results

I

The primary penicillin target: the penicillin binding

proteins (PBP). Pneumococci contain five high molecular
weight penicillin binding proteins (PBP la, lb, 2a, 2b and 3
resp.; (93)), which can be covalently labeled with radioactive
penicillin and visualized by fluorography after separation by
SDS-PAGE. In the present experiments, Cid+ pneumococci and the
Cid" mutant Cid-1 contained a similar set of PBPs, as measured
both by their migration on SDS-PAGE and as well as by their
affinity for radioactive penicillin (see figure 31, appendix VII,
p.154) .

II The secondary penicillin target: the cell wall and the
autolytic enzymes.

II.1 Susceptibility of Cid+ and Cid' purified cell walls to
digestion by the major autolysin amidase.

(i) The walls of untreated pneumococci: We have tested the
ability of purified amidase to solubilize continuously
radiolabeled (with [3H]-choline) purified cell walls prepared
from growing cultures of either Cid+ Lyt" (Lyt 4-4) or Cid" Lyt"
(T6) cells. Equal amounts of radiolabeled cell walls were
distributed into pre-chilled Eppendorf tubes containing
increasing amounts of amidase (from about 0.4 to 50 U/ml). The
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tubes were then incubated at 37°C for 20 min, after which the
reaction was stopped as described. The undissolved cell wall
material was pelleted and the radioactivity released to the
supernatant (solubilized wall) was counted in a scintillation
counter. The fraction of solubilized wall in each tubes was
expressed as the percent of the total radioactivity that was
released to the supernatant. Figure 10 C (p. 84) shows that the
titration curves of Cid+ and Cid" walls were parallel, indicating
that in these conditions both types of cell walls were
solubilized at the same speed by purified amidase.

(ii) The "newly-made" wall in penicillin-treated pneumococci.
It is known that even after addition of penicillin to the
cultures, pneumococci can still synthesize some residual cell
wall for some time (94). Therefore, it was possible that in Cid+
cells, such "newly-made" wall might be more susceptible to
digestion by amidase than in Cid" cells. To test this hypothesis,
growing cultures of either Lyt 4-4 (Cid+ Lyt") or T6 (Cid" Lyt")
received 20x the MIC of penicillin and, immediately after
addition of the drug, were labeled for 2 h with [3H]-choline,
until the experiment was stopped for cell wall purification.
Figure 10 D (p. 84) shows that again, both types of "newly-made"
walls were solubilized at virtually identical rate by amidase in
vitro. Thus, purified cell walls of either Cid+ of Cid"
pneumococci were equally susceptible to digestion by purified
amidase, whether or not the cells had been treated with
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The dashed line in panel A shows the growth of untreated control cultures.
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penicillin prior to wall purification, and whether or not the
cells had died as a consequence of antibiotic treatment.

II.2 Structural analysis of Cid+ and Cid" pneumococcal walls.
The lack of difference between the susceptibility of Cid+ and
Cid" cell walls to amidase digestion was further substantiated by
the absence of major differences in the structures of these walls
as analyzed by two biochemical techniques. First, the patterns of
peptide crosslinks between the stem peptides of both types of
peptidoglycans appeared to be identical, as shown by analysis of
wall hydrolysates by high performance liquid chromatography
(HPLC) (see Appendix III). Second, the proportion of cell wall
subunits bearing teichoic acids was also similar in both types of
cells, as determined by separation of "teichoicated" from "nonteichoicated" cell wall subunits by affinity chromatography (20)
(data not presented).
Thus, at least on the level of resolution allowed by the
analytical techniques, functional or structural differences in
cell walls were apparently not responsible for the different
behavior of Cid+ and Cid" cells during penicillin treatment. In
the next set of experiments, we have sought possible differences
between the levels of autolytic enzymes in both types of
bacteria.
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II.3 Activity of autolytic enzymes in extracts of Cid+ and Cid"
cells.

(i) Specific activity of amidase. We have already shown that
both the wild-type Cid+ Lyt+ strain R6x and the Cid" Lyt+ mutant
Cid-1 produced qualitatively and quantitatively equal amounts of
autolytic amidase, as measured by enzymatic activity in cell
extracts (see chapter I, tables 3-5, p. 40, 43 and 45 resp.).

(ii) Specific activity of a second wall acting hydrolase in Cid+
and CicT cells. In addition to the major autolysin amidase,
pneumococci contain a second enzyme the primary activity of which
appears to introduce breaks ("nicks") into the glycan chain of
the cell wall (17,74). A penicillin-induced abnormal activity of
such an enzyme could contribute to the killing effect of this
antibiotic. We compared the specific activities of this second
cell wall acting hydrolase in cell extracts prepared from Cid+
Lyt" (Lyt 4-4) and Cid" Lyt" (T6) pneumococci. Table 8 (p. 87)
shows that no difference was detected.
In an additional set of experiments (see Appendix IV) we
have further investigated the importance of such second "nicking"
murein hydrolase activity in penicillin-induced killing of
pneumococci. A new type of mutant (temporarily called Lys-2),
which overproduced such a "nicking" enzyme was generated by
insertion-duplication mutagenesis, with the suicide vector
pVA891. When transformed into Lyt" cells (either Lyt 4-4 or a
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Table 8:

Specific cell wall-hydrolysing activities in extracts of
isogenic C i d + and Cid" pneumococci

Enzyme
source5

Cell wall
substrate^

cell wall material released (%) atc:
37°C

30°C

Cid+ Lyt"

complete wall

1.6

3.6

Cid" Lyt"

complete wall

1.5

3.5

Cid+ Lyt"

HF-stripped wall^

8.12

Cid" L y f

HF-stripped wall^

7.85

a

Crude extracts were prepared as described in the text. Protein
concentrations were 1 mg/ml for Lyt" Cid+ pneumococci
and 1.1 mg/ml for Lyt" Cid" pneumococci.
b Cell walls that was biosynthetically labeled with radioactive lysine
were prepared from a L y t + C i d + strain (R6x; see text for details).
c
Hydrolysis of cell walls were measured after 18 h of incubation,
as described in the text.
d Cell walls were treated H F to remove teichoic acid (see text).
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double insertion-inactivated mutant (lytA::em::cm), the Lys-2
mutation produced a consistent increase in the rate of
penicillin-induced lysis (see figure 11, p. 89), which was not
due to the major autolysin amidase, but resulted from the
introduction of breaks in the cell walls (see inset in figure
11). In the Cid"Lyt" mutant T6, lysis was also increased by Lys2. These wall lesions were genuine "nicks", because they were not
accompanied by cell wall solubilization. However, while the Lys-2
mutant overproduced a "nicking" enzyme that might be the analog
of the "second" pneumococcal murein hydrolase described by Lopez
et al (17,74), the mutation did not increase the rates of
penicillin-induced killing in either Cid+ or Cid' pneumococcal
transformants (see figure 11 bottom panel).
Thus, as with cell wall susceptibility to amidase in vitro,
no differences were found in the levels of either one of the two
known autolysins between Cid+ and Cid" cells. Therefore, the
decreased penicillin-induced lysis observed in the Cid" Lyt+
mutant Cid-1 may be mediated by a completely different mechanism,
possibly through limitation (regulation) of the access of
autolytic enzymes to their substrate, the cell wall. This
hypothesis was tested in the experiments to be described next.
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Figure 11:

Cultures of either Lyt 4-4 (Lyt"; closed symbols) or the Lys-2 mutant overproducing
a nicking enzyme (open symbols) were treated with 20x the M I C of penicillin
(arrow) and O D 5 2 0 (panel A ) and viable counts (panel B ) were followed. The insets
in panel A show that the Lys-2 mutant accumulated substantially more breaks
or "nicks" (arrows) in the cell wall than the control strain Lyt 4-4 during penicillin
treatment These "nicks" were not accompanied by cell wall solubilization as Lys-2
cultures radiolabeled in their cell walls did not release radioactivity during penicillininduced lysis (see appendix IV). The dashed line in panel A depicts the growth of
untreated control cultures.
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III. Physiological investigations on penicillin-induced killing
and lysis of Cid+ and Cid" pneumococci.

Ill.l Access of amidase to its cell wall substrate in the in
vivo context.

As suggested above, the cid" mutation might

control penicillin-induced lysis of Lyt+ cells by limiting the
access of the enzyme to its cell wall substrate. Since amidase is
constitutively produced in Lyt+ pneumococci (i.e., pneumococci
that bear a functional lytA gene; (12)), such control must occur
at the post-translational level, anywhere between the step of
membrane export to that of regulation of the enzymatic activity
in situ (i.e., within the cell wall).
In order to better define this control mechanism, a simple
experiment was devised. The system relied on the fact that the
physiological transport of amidase to the wall (which is not yet
understood) could be bypassed by adding the enzyme from outside
the cell. It has been shown that addition of purified amidase to
cultures of Lyt' pneumococci could fully restore penicillininduced lysis in these bacteria (83). Therefore, Cid+ Lyt" and
Cid" Lyt" pneumococcal cultures supplemented or not with purified
(exogenous) amidase were exposed to 20x the MIC of penicillin,
and both survival and 0D62O were followed.
Figure 12 A and C (p. 92) shows that addition of exogenous
amidase to Cid+ Lyt" (Lyt 4-4) cultures restored wild-type
penicillin-induced lysis (as expected), while it had only
marginal influence on bacterial survival. This was in accordance
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with previous observations showing that, lysis was not the
primary killing factor during penicillin treatment of
pneumococci.
In contrast, however, penicillin-treated cultures of Cid"
Lyt" cells were very poorly lysed by exogenous amidase and
killing was not increased by the enzyme either (figure 12 B and
D, p. 92)). Thus, when assembled back in its in vivo context, the
wall of Cid" cells could barely be lysed by exogenous amidase, in
spite of the fact that it was fully sensitive to amidase
degradation in vitro. This discrepancy supported the hypothesis
that the autolytic system was controlled by an alternative
element, that was fully expressed in whole cells and was involved
in the regulation of both penicillin-induced killing and lysis.
A clue for the cellular localization of such element was
provided by the observation that Cid" cells were rapidly lysed by
treatment of the cultures with the detergent DOC (figure 12 B, p.
92). Since detergents primarily alter the stability of the
cellular membrane, it is likely that the common target
controlling both penicillin-induced killing and lysis operates at
the level of the plasma membrane. A model for such an element is
presented in the discussion (see also figure 13, p. 99).

III.2 Additional investigations on the nature of penicillininduced killing.

Two additional sets of experiments were

performed to better specify the nature of the bactericidal lesion
of penicillin in the cell (see Appendixes V and VI).

91

Lyt 4-4 (Cid + )

T 6 (Cid")

DOC

i

- 1 0

'

i

'

1

2
tlme(h)

i

'

i

3

•

i

4

10° -

1

Figure 12:

0

n '
r
1
2
time (h)

1
2
time (h)

The cid~ mutation interferes with the access of amidase to its cell wall substrate.
Cultures of both Lyt 4-4 (Cid + Lyt"; panels A and C ) and T 6 (Cid" Lyt"; panels B
and D ) received amidase (25 U/ml; closed squares) or no enzyme (open squares) 30
min before treatment with 20x the M I C of penicillin (arrow). Untreated control
cultures (dashed line) were not affected by addition of amidase. Optical density and
viable counts were followed over time. Note that addition of D O C to the Cid" mutant
T 6 fully restored lysis by amidase (see dotted line in panel B).
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(i) Penicillin-induced degradation of bacterial RNA.

In group A

streptococci, which are exquisitely sensitive to the bactericidal
effect of

penicillin, while notably resistant to antibiotic-

induced lysis (27,55), penicillin-induced killing has been
associated with intracellular degradation of RNA (56). It was
suggested that the cidal effect of the drug might be mediated by
some antibiotic-induced activity of endogenous nucleases. We have
tested whether degradation of radiolabeled RNA might be different
in penicillin-treated Cid+ and Cid" pneumococci (see Appendix V ) .
No difference was observed.

(ii) Survival of penicillin-treated pneumococci in osmoticallyprotective medium. Experiments in which Cid+ Lyt+ (R6x) and Cid+
Lyt" (Lyt 4-4) pneumococcal strains were grown and treated with
penicillin in osmotically-protective medium (containing 30% of
raffinose and 20 mM of Mg++) are described in Appendix VI.
Adequate conditions permitted the conversion of penicillintreated Lyt+ bacteria to stable protoplasts. As expected, similar
treatment of Lyt' cells did not induce alteration of the
bacterial shape. Surprisingly, however, in spite of the fact that
the medium provided osmotic protection and also supported
bacterial growth, penicillin treatment resulted in identical
bacterial killing, whether or not the cultures had been grown in
osmotically-protective media. Therefore, in these experiments,
protection against osmotic imbalance did not prevent penicillininduced killing of pneumococci.
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Discussion

Taken together, these results support the hypothesis
presented in chapter I, that cid controls both penicillin-induced
killing and lysis by altering the function of a "new" penicillin
target. Indeed, both functional and structural analysis of the
known primary and secondary penicillin targets of pneumococci
showed no major differences between Cid+ and Cid" cells. First,
both types of pneumococci contained a "normal" set of PBPs (as
determined by migration on SDS-PAGE) with similar affinity for
penicillin, which was also consistent with the unchanged MIC
value of the drug for Cid" as compared to Cid+ bacteria. Second,
neither the composition of cell walls nor the levels of two
autolytic enzymes seemed to differ in Cid+ and Cid" pneumococci
when tested in vitro. Therefore, the cid" mutation was likely to
operate at the level of some other target(s), only functionally
linked to the "classical" penicillin targets of bacteria.
A clue for the physical localization of the Cid" alteration
came from the experiments in which exogenous amidase was added to
Lyt" pneumococcal cultures prior to penicillin treatment. This
reconstitution experiment allowed to challenge the effect of the
cid" mutation in a system where the wall was in its nin vivon
context, but the transport of amidase through the plasma membrane
was bypassed. Unexpectedly, the cid" mutation was also able to
control penicillin-induced lysis in these conditions.
Importantly, however, instantaneous cell lysis was restored by
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treatment of the cultures with the detergent DOC. This indicated
that alteration of some lipophilic structure in the bacteria
could nullify the protective effect of cid" on amidase-induced
lysis. The major structure to be altered by such treatment is
obviously the plasma membrane.
The implication of the plasma membrane in the regulation of
autolysis has long been recognized (82). However, the
mechanism(s) by which membrane molecules regulate autolysis is
incompletely understood. For instance, the transport of the
pneumococcal amidase and other lytic enzymes (including
bacteriophage-encoded lysins) across the plasma membrane remains
an enigma (12). Since neither the lytA gene, nor the genes of
known phage lysins encode for a signal sequence, the enzymes are
likely to use some host or phage-encoded channel proteins (to be
referred to as "holin" in accordance with the proposition of
Young (96)) to reach their cell wall substrate. However, such
autolysin-transport holins have yet to be isolated in
pneumococci.
Once across the membrane, the autolysin amidase becomes
anchored to the plasma membrane through the choline-containing
(membrane-bound) lipoteichoic acids or LTA (3,35,82). LTA are
unique glycolipid-linked pneumococcal teichoic acids, which are
strong inhibitors of amidase. In conditions that promote cell
lysis, LTA are released to the supernatant (3,82). Experimental
evidence suggests that during that process, amidase molecules
attached to the choline residue of the LTA might progressively
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exchange for the choline residue of the pneumococcal cell wall
teichoic acids (which typically contain choline), allowing the
enzyme to be properly positioned in the peptidoglycan and
hydrolysis of the cell wall to proceed (51). Since LTA molecules
are membrane-bound glycolipids, their release must involve some
disturbance(s) of the plasma membrane. However, the factors
triggering the release of LTA molecules from the membrane are not
known.
While it is conceivable that the protective effect afforded
by

cid" was due to some sophisticated change in the cell wall

structure of Cid" cells, this is unlikely because Cid" Lyt+ cells
were lysed normally by DOC and because amidase can rapidly and
completely degrade cell walls prepared from Cid" Lyt' cells. We
favor an alternative model, in which the cid product operates at
the level of the plasma membrane, controlling the access of
autolytic enzymes to the pneumococcal cell wall - both from
within as well as from without - and/or providing a mechanism of
transport of other surface-related macromolecules. We propose
that the cid protein performs such a physiological function at
some low copy number per cell, and a substantial increase in the
copy number of this protein would be toxic for the bacterium (see
figure 13, p. 99).
We assume that the toxicity of a high concentration of

the

Cid protein involves some injury (increased selective
permeability?) to the plasma membrane, the integrity of which is
essential for the survival of the bacteria. The same injury would
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allow the release of large amounts, unregulated forms, or both of
the autolytic enzymes to the cell wall. The death of completely
amidase-deficient cells may be caused by the membrane injury per
se, or it may be mediated by breaks (nicks) introduced into the
cell wall by some wall-acting hydrolase. The latter hypothesis,
however, is less convincing in view of our negative observations
with the so-called Lys-2 mutants (see Appendix IV).
The model is formally analogous to the mechanism proposed
for the triggering of autolytic activity by penicillin (82) and
is also similar to models proposed for the mechanism of cell
lysis induced by the bacteriophages lambda, #X174 and MS2
(22,24,30,96). An instructive precedent for such a suggestion
exist in the bacteriophage lambda lytic system. While the
bacterial host is lysed at the end of the virus replicative
cycle, killing and lysis are clearly two separate phenomena.
Bacterial death results from perforations of the plasma membrane
by a so-called S protein, which channels the phage encoded lytic
enzyme (lysozyme) from the cytoplasm to the periplasmic space.
Lysis is due to peptidoglycan digestion by this second enzyme.
Mutants in the lytic enzyme are not lysed by the phage, but
extensively killed by the production of the S protein. On the
other hand, mutants in the S protein are not killed by the virus
and, as expected, not lysed either (see figure 13, p. 99)(96).
To envision the mechanism of autolysis-independent death, we
propose that the cid gene is under the negative control of a
repressor which is composed of cell wall material (cell wall

97

precursors of cell wall metabolites). We cannot speculate about
the precise chemical nature of this repressor, except to suggest
that its production is inhibited by antibiotics that inhibit cell
wall synthesis (and maybe also DNA replication as shown by
increased resistance of Cid" mutants to killing by temofloxacin,
see Chapter II). We do not know whether the cid" mutation, which
allows increased resistance to antibiotic-induced killing, is in
the structural gene of the Cid protein or in some regulatory
element. It is possible that the well known resistance of dormant
(non-growing) bacteria to the killing effect of cell wall
inhibitors is also mediated by the cid system.
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Figure 13:

Model for a mechanisms of autolysis-independent killing of pneumococci by cell wall
inhibitors. Cell death is controlled by the cid gene product (the Cid protein), which
operates at the level of the plasma membrane, controlling (directly or indirectly) the
access of autolytic enzymes (black dots on thefigure)to the pneumococcal cell wall
and providing a mechanism of transport of other surface-related macromolecules. Cid
performs such a physiological function at some low copy number per cell. During
normal bacterial growth (left panel), Cid is controlled by a putative repressory circuit
which is driven by the rate of cell wall (and/or other biopolymers) synthesis.
Inhibition of peptidoglycan synthesis during treatment with cell wall inhibitiors (right
panel) alters the Cid regulatory circuit and results in an increased production of the
Cid protein. High concentrations of Cid might produce some irreversible injury to
the plasma membrane and allow the release of large amounts and/or unregulated
forms of autolytic enzymes to the cell wall. The death of amidase-deficient bacteria
m a y be caused by the membrane injury per se, or m a y be mediated by some subtle
changes (nicks) introduced in the cell wall by alternative wall-acting hydrolase. The
model does not specify the number or nature of factors that participate in the killing
of autolysin-defective pneumococci.
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Chapter IV

The effect of penicillin treatment on the synthesis of cellular
biopolymers.

Summary of results

There is little doubt that killing and lysis of pneumococci
are at the end of a pathway initiated by the inhibition of the
membrane bound penicillin binding proteins by the antibiotic.
While in wild-type pneumococci it is technically impossible to
analyze the initial events of this pathway, the availability of
isogeneic Cid+ Lyt" and Cid" Lyt" pneumococcal mutants provided an
experimental system for such an analysis. The fact that neither
of the mutants underwent lysis, while they differed widely in
their ability to survive penicillin treatment, should permit one
to differentiate between the phenomena related to cell death from
phenomena that represent the largely reversible - growth
inhibitory - effects of penicillin, observable in the Cid' Lyt"
cells.
We examined in detail two specific - conceivable mechanisms. Since it is well known that inhibition of protein
synthesis renders the cells unresponsive to both penicillininduced killing and lysis (85), was it possible that Cid" cells
were able to shutoff protein synthesis more rapidly than Cid+
parents in response to antibiotic treatment, and thus evade the
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irreversible effect of the drug treatment? A mechanism of this
sort would be expected from the "unbalanced growth" model for
penicillin lethality (84). The availability of Lyt" pneumococci
also enabled us to test whether or not penicillin-induced killing
was related to the synthesis of some toxic protein, which may be
detected by a careful examination of polypeptide synthesis during
penicillin treatment of Cid+ and Cid" pneumococci.
The results presented in this chapter showed that the answer
to the first question was negative: Cid" bacteria did not turnoff polymer synthesis faster than Cid+ bacteria, indicating that
this was not the mechanism preventing penicillin-induced killing
in Cid' pneumococci. Examination of polypeptide synthesis in Cid+
and Cid" cells yielded several unexpected, novel observations. In
both types of cells, penicillin treatment resulted in a rapid and
complete shutoff of protein synthesis. In addition, specific
radioactive labeling of a unique protein of ca. 72 kD molecular
size with [35S]-cysteine was induced and/or continued, even when
radioactive labeling of other bacterial proteins had come to a
virtual halt. Labeling of the 72 kD protein decreased after
removal of the drug from the medium leading to a resumption of
bacterial growth. The 72 kD protein might be labeled in response
to antibiotic-induced inhibition of biopolymer synthesis and it
may participate in a regulatory circuit that shuts off polymer
synthesis in penicillin-treated bacteria.
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Materials and Methods

Microorganisms and growth conditions.

The isogeneic pair of

Cid+ Lyt" and Cid" Lyt" pneumococcal mutants Lyt4-4 and T6 were
used in most of the experiments to be described next.

In

addition, some experiments were also performed with
representative strains of other streptococcal species, including
S. bovis, S. sanguis, S. salivarius, group B Streptococcus and S.
mitis. All these organisms were clinical isolates susceptible to
penicillin (MIC < 0.1 ug of penicillin/ml), except for the strain
of S. mitis, which was resistant to the drug (MIC = 2 /zg/ml).
Unless otherwise stated, liquid cultures of the bacteria were
grown at 37°C without aeration in the chemically defined medium
Cden (see Materials and Methods in Chapter I), from which the
normal content of either uridine, L-phenylalanine or L-methionine
had been omitted.

In some experiments, this medium was

supplemented with 0.1% (w/v) of yeast extract (Difco) to enhance
bacterial growth.

Cultures growth and viable counts were

followed as described.

Antibiotics and reagents. Benzylpenicillin and the vancomycin
derivative LY-A47934 were obtained from Eli Lilly and Co.;
cefotaxime from Hoechst-Roussel Pharmaceuticals Inc. (Somerville,
NJ); erythromycin, chloramphenicol, rifampin, mitomycin-C,
streptomycin and chlorate from Sigma and penicillinase
(Penicillinase Concentrate) from Becton Dickinson and Co.
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(Cockeysville, MD). The radiochemicals were as follow: (i)
L-[alanine-2,3-3H]-phenylalanine (21.6 Ci/mmol) and
[5-3H]-uridine (25.8 Ci/mmol) were obtained from Dupont, NEN
Research Products (Boston, MA); (ii) [35S]-sodium sulphate (9.69
mCi/ml), TRAN35S-LABEL (a mixture of 70% of L-[35S]-methionine and
15% of L-[35S]-cysteine; >1000 Ci/mmol) and L-[35S]-cysteine
(translation grade; >800 Ci/mmol) were obtained from ICN
Biomedicals, Inc. (Costa Mesa, CA) and (iii) L-[U-14C]-amino acid
mixture (lacking both methionine and cysteine; 50 /iCi/ml),
L"[35S]-methionine (>800 Ci/mmol) and L-[methyl-"C]-methionine
(70-85 Ci/mmol) were obtained from Amersham Corp. (Arlington
Heights, IL). The chemical used for protein electrophoresis were
purchased from Bio-Rad Laboratories (Richmond, CA). All other
chemicals were reagent grade, commercially available products.

Drug treatment and heat shock. Bacteria were grown at 37°C in
200-500 ml cultures to an 0D620 of 0.2-0.3 (corresponding to 0.5-1
x 108 CFU).

At this time, the master culture was split in 20-100

ml portions that received immediately 20x the MIC of either
penicillin, or one of the other antibiotics listed above.

For

each drug (or temperature condition) a culture treated with
penicillin was tested in parallel as a control.

0D62o and colony

counts were followed and rates of protein or RNA synthesis were
determined as described below.
In certain experiments, penicillin was inactivated in situ
after 2 h of treatment by the addition of 1,000 U of
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penicillinase/ml (final concentration) to the cultures, and
resumption of growth (as measured by increase in both 0D620 and
colony counts) and protein synthesis were followed.

In other

experiments, the effect of heat shock was investigated by
transferring one portion of the culture to a 45°C water bath.
Finally, in some experiments, pneumococcal (Lyt 4-4) cultures
were grown in subinhibitory concentrations (1/10 - 1/2 x the MIC)
of chlorate (MIC for Lyt 4-4 = 10 mM), a potent oxidant also
known to inhibit protein tyrosine sulphation in eukaryotic cells
(4).

Rates of protein and RNA synthesis. Strains of pneumococci
were grown at 37°C in 100 ml volumes of Cden minus phenylalanine
and uracil, but supplemented with yeast extract.

At an 0D620 of

0.2 to 0.3 (corresponding to 0.5-1 x 10s CFU/ml), 20x the MIC of
penicillin was added to the cultures and incubation was
continued.

Rates of synthesis of protein and RNA were determined

by pulse-labeling the cells with [3H]-phenylalanine or [3H]uridine at several times before and after the addition of
penicillin: 0.950 ml samples of the cultures were pipetted into
prewarmed (37°C) borosilicate tubes (12 x 75 mm) containing 50
jLtl of either [3H]-phenylalanine (5 fiCi and 0.04 ug) or [3H]uridine (5 /iCi and 0.044 ug), incubated for 5 min at 37°C, and
rapidly frozen in dry ice. Eventually, the samples were thawed,
treated for 30 min with 10% (w/v; final concentration) ice cold
trichloroacetic acid to precipitate proteins and RNA, and
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filtered through either 0.45

JLUQ

pore size filters (Millipore)

(for proteins) or glass microfiber filters (Whatman, Inc.,
Clifton, NJ) (for RNA).

The filters were rinsed extensively with

a 10 mg/100 ml solution of cold phenylalanine or uridine, dried,
and transferred to vials containing Ready Safe liquid
scintillation cocktail (Beckman Instruments).

All [3H]-labeling

experiments were performed in triplicate.

Radiolabeling of proteins for gel electrophoretic analysis. At
several time points before and during drug or heat treatment, the
cultures were labeled with various radioactive precursors.
Aliquots (4.5 ml) of the cultures were transferred into prewarmed
(37°C) 15 ml plastic-capped tubes containing adequate amounts of
radioactive tracer (see details below) diluted in 0.5 ml of
medium.

Incubation was continued for 7 min before labeling was

interrupted by one of the methods to be described next.
(i)

For pulse labeling experiments, labeling was stopped by

the addition of 5 ml of ice cold 20 mM Tris HC1 pH 8 buffer
containing a 50-100 x excess of the same non-radioactive
precursor, in order to dilute out the radioactive tracer.

The

radioactively labeled cells were harvested by centrifugation (at
4°C), thoroughly washed 2x with 10 ml of the same buffer and
resuspended in a final volume of 50-100 /xl of buffer.

The cells

were lysed either enzymatically (by addition of 0.1% of DOC and
ca. 20 U of purified amidase followed by incubation for 15 min at
37°C) or by sonication for 7-10 min in an Ultrasonic Cleaner
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(Branson Cleaning Equipment Company, Shelton, CT). Successful
lysis (i.e., lysis of >99% of the cells) was assessed by phase
contrast microscopy.
(ii) For pulse-chase experiments, the cells were submitted
to a similar 7 min radioactive pulse, but were then filtered
through a 0.45 /im HA Millipore filter (Millipore Corp., Bedford,
MA) saturated with "cold" precursor, and copiously washed with
plain prewarmed medium before being resuspended at an 0D620 of
0.2-0.3 in plain medium.

Incubation was continued for a

determined period of time before the reaction was stopped and the
samples were processed and lysed as described above.
(iii) Finally, in some experiments, protein synthesis of the
bacteria was blocked prior to radiolabeling by
filtration-resuspension of the cells in Cden lacking the
essential amino acid leucine.

Radiolabeled precursors and specific activities. The radioactive
tracers used were as follows: (i) a mixture of L-[3SS]-methionine
(40 jiCi/ml and 500 nmol/ml) and L-[35S]-cysteine (8,5 /LiCi/ml and
200 nmol/ml), (ii) L-[35S]-methionine (20 /iCi/ml and 500
nmol/ml), (iii) L-[35S]-cysteine (2 jLiCi/ml and 200 nmol/ml), (iv)
[35S]-sulphate (sodium salt; 2.5 juCi/ml and 0.1 nmol/ml), (v)
L-[methyl-14C]-methionine (1.3 /iCi/ml and 500 nmol/ml) and (vi)
L-[U-14C]-amino acid mixture (lacking both methionine and
cysteine; 0.5 /uCi/ml and approximately 100 /ig/ml).
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Protein analysis.

The protein profile of the cell lysates was

analyzed on one and two dimensional polyacrylamide gel
electrophoresis (PAGE), in reducing conditions (46,66).
Isoelectrofocusing (IEF) was run on 8% PAGE containing 8 M of
urea, 2% (v/v) of NP40 and 5% (w/v) of a mixture of 1/3 of
ampholines of pH 3-10 and 2/3 of ampholines of pH 4/6
(Bio-Lytes). SDS-PAGE was run on 10% PAG containing 0.1% (w/v) of
SDS.
Peptide mapping of selected protein bands was performed by
partial protein digestion with V8 protease (Sigma). In brief, gel
slices containing the band of interest were cut out of the first
10% SDS-PAGE and, after thorough washing with 0.125 M Tris buffer
at pH 6.8, loaded sideways on a second (15%) SDS-PAGE which was
surmounted by a stacking gel containing 0.2 ug of V8 protease/ml
and devoid of SDS.
The gels were stained with Coomassie blue or silver stain
and dried, either directly or after soaking in Enlightning (NEN),
before exposure to Kodak X-OMAT AR films (Eastman Kodak Company,
Rochester, NY) for autoradiography or fluorography.

Intensities

of the radioactive bands were quantified by autoradiography on
storage phosphor screens, using the PhosphorImager and the
ImageQuant software version 3.0 (Molecular Dynamics, Sunnyvale,
CA).

Amino acid analysis. In certain experiments, it was necessary
to determine the presence of L-[35S]-cysteine in the radiolabeled

107

proteins.

Total (radiolabeled) cell proteins were precipitated

with 10% ice cold trichloroacetic acid (for 30 min), thoroughly
washed with acetone, dried and oxidized with performic acid to
convert cysteine to cysteic acid in order to protect its sulphur
group from hydrolysis during further acid hydrolysis of the
peptide bonds.

Amino acids were hydrolyzed for 20 h at 110°C in

6 N HC1 and separated on a Dowex (anion exchange) column (kindly
performed by Dr. Manning, The Rockefeller University).

Amino

acid fractions were recovered and tested for the presence of
radioactivity by liquid scintillation counting.

Separation of

[35S]-cysteic acid from possible contamination with [35S]-sulphate
was performed by paper chromatography using a solvent containing
10 ml of ethanol, 4.5 ml of H20 and 0.5 ml of acetic acid.
For amino acid sequencing of radiolabeled protein peptides,
the protein band of interest was partially digested with V8
protease followed by separation of the peptides by SDS-PAGE (as
described for peptide mapping, see above).

The peptides were

transferred to Immobilon-P (PVDF) Transfer Membrane (Millipore)
using the MilliBlot-SDE Transfer System (Millipore).

After

autoradiography of the membranes, the desired radioactive spots
were cut out and pooled for further amino acid sequencing.
Protein analysis was provided by the Rockefeller University
protein sequencing facility.9

'Supported in part by NIH shared instrumentation grants and
by funds provided by the U.S. Army and Navy for purchase of
equipment.
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Results

Synthesis of biopolymer in pneumococci treated with penicillin.

I. Kinetics of growth inhibition after the addition of
penicillin.

We used isogeneic pairs of Cid" Lyt" and Cid+ Lyt"

cultures to compare the rates with which Cid' and Cid+ cells
slowed growth rates (as measured by increase in 0D620) and rates
of protein and RNA synthesis after the addition of penicillin.
Figure 14 (p. 110) shows that the rates of growth and protein and
RNA synthesis decreased in the two cultures at virtually
identical initial rates. The differences in the rates of protein
and RNA synthesis after longer times of incubation with
penicillin presumably reflected the very substantial difference
in the number of viable bacteria in the Cid' versus those in the
Cid+ cultures (figure 14-A). However, the decrease in the rates
of macromolecule synthesis over time was not proportional to loss
of viability. At 1 h, for instance, the rates of protein
synthesis were still virtually identical in both cultures,
whereas Cid+ cells had already lost >10x more viable cells than
Cid" cultures. A similar trend was also observed for RNA
synthesis.
Cid+ and Cid" cells also synthesized similar amounts of
residual cell walls after addition of penicillin. This was shown
by equal incorporation of radioactivity/mg of purified cell walls
in bacteria labeled for 2 h with [3H]-choline after the addition
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Figure 14:

Kinetics of growth inhibition and loss of viability after the addition of penicillin. (A)
Cultures of isogeneic pairs of C i d + Lyt' (Lyt 4-4; open symbols) and Cid" Lyt"
(T6; closed symbols) pneumococci in the exponential phase of growth received 20x the
M I C of penicillin at 0 h, and the effect of antibiotic treatment on the cultures' O D 5 2 0
(dashed lines) and loss of viability (solid lines) was monitored. Panels B and C show
the effect of penicillin treatment on the rates of proteins (B) and R N A (C) synthesis,
as determined by pulse-labeling samples of the cultures for 5 min with either p H ] phcny lalaninc (panel B ) or {^H]-uridine (panel C), followed by measurement of the
number of counts per minute incorporated by the cells in trichloroacetic acidprecipitable macromolecules during this period of time (see text). Each dot in panels
B and C represent the m e a n ± standard deviation of three determinations.
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of the drug (i.e., 6x 104 cpm/mg of wall for Cid* cells and 7x 104
cpm/mg for Cid' bacteria).
Thus, no major differences were detectable in the initial
rates of growth inhibition in these two organism, and inhibition
of polymer synthesis occurred with the same initial rates in both
cases. The next series of experiments present a more detailed
analysis of the shutoff of protein synthesis produced by
treatment with penicillin.

II. The effect of penicillin on protein synthesis in
pneumococci.

Cultures of Cid+ Lyt" and Cid" Lyt" pneumococci

were pulse-labeled with a mixture of [35S]-methionine and [3SS]cysteine (Tran35Slabel) at various times before and after the
addition of 20x the MIC of penicillin to the bacteria.
Incorporation of radioactive amino acids in proteins was
quantified by autoradiography using the Phosphorlmager after
separation of the polypeptides by SDS-PAGE. Figure 15 A and B (p.
112) show that in both kinds of pneumococcal cultures
incorporation of radioactive amino acids underwent a rapid
decline following administration of the antibiotic, which
confirmed the phenomenon observed in the previous section (figure
14, p. 110). However, another striking feature of the
autoradiogram, besides the complete halt of synthesis of most
polypeptides, was the continued (and/or induced) labeling of a
single band of approximately 72 kD molecular size.
In the following, we shall briefly analyze first the shutoff
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Figure 15:

Shutoff of protein synthesis during penicillin treatment. Cultures of the C i d + Lyt"
strain Lyt 4-4 (left panel) or the Cid" Lyt" strain T 6 (right panel) were treated in the
exponential phase of growth with 20x the M I C of penicillin. After 2h of treatment,
penicillin was inactivated by the addition pencillinase (10^ U/ml) to the medium. At
several time-points before and after addition of penicillin, samples were removed and
pulse-labeled for 7 min with "Tran^Slabel" before being lysed and processed for
separation by S D S - P A G E and autoradiography. The upper part of the figure shows
the O D 5 2 0 (dosed symbols) and viable counts (open symbols) during the course of the
experiment. The lower part of thefigureshows the auto radiograms of the
radiolabeled cellular proteins. The lanes were loaded with equal amounts of proteins.
N o differences in the protein profiles were observed on Coomassie blue stained gels.
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of protein synthesis, and then the nature and regulation of the
72 kD radiolabeled species.

II.1 Shutoff of protein synthesis. Figure 15 A and B show that
incorporation of the tracer had come to a virtual halt in all the
polypeptides (except the 72 kD species) after about 90-120 min of
exposure to penicillin. During this period of time, no striking
changes had occurred in the profile of the bacterial bulk
proteins as visualized on Coomassie blue stained gels. Both Cid+
and Cid" cultures stopped growing (as measured by the 0D62O),
however, Cid+ cells lost viability (about 2 Log units in 2 h)
while there was only a minor decline in viable titers in the Cid"
culture (< 0.5 Log unit in 2 h). The disproportionality between
loss of viability and decline in protein synthesis was even more
striking in figure 16 (p. 114), which shows the quantitation of
the radioactive labeling of the protein bands by densitometry on
the PhosphorImager (Molecular Dynamics). It can be seen that
while survival of Cid+ and Cid' cells was very different (open
squares in the figure), the reduction in the rates of synthesis
of most polypeptides (as measure by the total intensity of the
lanes on the autoradiograms) and that of a major band "I" (for
its remarkable decrease in intensity during penicillin treatment)
were almost identical. Moreover, after in situ inactivation of
penicillin by penicillinase, protein synthesis resumed somewhat
faster than cell division (as measured by the increase in colony
counts) in both kinds of organisms.
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Kinetics of penicillin-induced killing (open symbols) and shutoff of protein synthesis
(closed symbols) were measured in cultures of C i d + Lyt" (strain Lyt 4-4; left panel)
and Cid" Lyt' (strain T6; right panel) pneumococci. Cultures of either strains were
treated with 20x the M I C of penicillin and pulse-labeled with "Tran^Slabel" and the
protein content of cell lysates were analyzed by S D S - P A G E and autoradiography as
infigure16. Intensities of the bands were quantified using the Phosphorlmager and
the ImageQuant software version 3.0 (Molecular Dynamics). Shutoff of total protein
synthesis (closed circles) was determined by measuring the intensities of total lanes.
Shutoff of so-called Band 1 (closed squares; seefigure16), was followed for
comparison because it represented a major protein species on the gel.
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This observation suggested the possible existence of a
global regulatory mechanisms, which was triggered by penicillin
treatment and resulted in shutoff of protein synthesis, whether
or not the cells had been killed (i.e., were unable to divide) by
the drug. This hypothesis was confirmed by experiments in which
Cid+ Lyt" pneumococci were treated with non-cidal cell wall
inhibitors. Figure 17 (p. 116) shows that the B-lactam cefotaxime
and the vancomycin derivative LY-A47934 resulted in a substantial
inhibition of protein synthesis (and also in the labeling of the
72 kD band), in spite of the fact that they did not kill Lyt 4-4
pneumococci.
Thus, inhibition of protein synthesis was a genuine
consequence of cell wall inhibition, which was mediated by a
regulatory circuit that has yet to be defined. Inhibition of
synthesis was extensive as it approached that of specific protein
synthesis inhibitors such as chloramphenicol and erythromycin
(see figure 22, p. 126). Moreover, the phenomenon was not
confined to pneumococci, since general shut off of protein
synthesis was also observed in several other Lyt" streptococcal
species during penicillin treatment (see figure 18, p 117).

II.1 The nature and regulation of the 72 kD radioactively labeled
band.

Penicillin treatment of wild-type pneumococci is known

to cause massive perturbation of the cells surface. While
autolysis and viability loss were eliminated in the particular
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Figure 17:

Cultures of the Cid + Lyt" strain Lyt 4-4 in the exponential phase of growth were
treated with 20x the M I C of either penicillin, cefotaxime or the vancomycin
derivative LY-A47394 at 0 h (arrow). O D g 2 0 (panel A ) and viable counts (panel B )
in the cultures were followed. At different time-points, samples of the cultures were
removed, pulse-labeled with "Tran^SIabel" as described, lysed and processed for
autoradiography. The autoradiograms are shown at the bottom of thefigure.Ctx
stands for cefotaxime and V for the vancomycin derivative LY-A47394.
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Figure 18:

Penicillin-induced shutoff of protein synthesis was also observed in nonpneumococcalstreptococci. Cultures of clinical isolates of bacteria representative of
several different species of streptococci were treated with 20x the M I C of penicillin
(arrow in panel A ) and O D 6 2 0 and viable counts in the cultures were followed
(panel A ) . At different time-points, samples of the cultures were removed, pulselabeled with "Tran^Slabel" as described and processed for autoradiography.
Panel B shows the autoradiograms of samples labeled just prior to the addition of
penicillin to the cultures (0 h) and 2. 5 h later. For each bacterial species, the lanes
were loaded with similar amounts of proteins.
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mutants used on our experiments, production of more complex
artifacts during the penicillin treatment of the latter mutants
could not be a priori excluded. For this reason, we performed a
series of experiments aimed at the elucidation of the nature of
the radioactively labeled 72 kD band.

(i) The 72 kD band is a protein. The 72 kD band was completely
destroyed by digestion with trypsin, but not by trypsin plus
soybean protease inhibitor. The band was also digested by V8
staphylococcal protease and pronase, but not by nucleases.
Conditions of partial proteolysis with V8 protease resulted
in the production of several radioactively labeled peptides
(figure 19, p. 119). The figure also shows that under the same
conditions of partial proteolysis a 72 kD radioactively labeled
material produced by pneumococci treated with chloramphenicol
(instead of penicillin) produced a set of radioactively labeled
peptides which were indistinguishable from the proteolytic
products produced from the protein seen in penicillin-treated
cells.
The 72 kD protein did not show up when the cells were lysed
prior to pulse-labeling, indicating that labeling required
cellular integrity. The 72 kD labeled band did not appear in the
supernatant of radiolabeled cells. However, upon cell
fractionation, the band partitioned in approximately equal
amounts in both soluble and particulate (membrane enriched)
fractions. The band was apparently not attached to the bacterial
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Figure 19:

Peptide mapping of the 72 k D radiolabeled protein. Cultures of Lyt 4-4
were treated with 20x the M I C of penicillin (or chloramphenicol), pulselabeled as described and proteins of cell lysates were separated by S D S P A G E (panel A ) . For partial proteolytic mapping, the lanes containing the 72
k D protein were cut out and loaded sideways on a second S D S - P A G on top of
which the stacking gel was devoid of S D S and contained V 8 protease (panel
B; see text for details). The peptides were separated by electrophoresis and
the second dimension gel was processed for autoradiography. Radioactive
peptides are indicate by the arrow-heads in panel B.
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cell walls, because walls had been enzymatically digested by
amidase during cell lysis. Therefore, the protein was likely to
be partly attached to the plasma membrane. Interestingly,
treatment by high salt (1M NaCl or 1M LiCl) did not release the
band from the particulate fraction (see figure 32, appendix VIII,
p. 155)

(ii) Nature of the labeling of the 72 kD protein. Upon repeating
the pulse-labeling experiment with pure [35S]-methionine or with
mixture of [14C]-labeled amino acid (lacking cysteine) it was
found that while inhibition of protein synthesis with penicillin
was complete, there was no radioactivity appearing in the region
of the 72 kD molecular size on the autoradiograms. This finding
suggested that the labeling of this band in the experiments
illustrated in figure 15 A and B (p. 112) was due to the second
component of the Tran35Slabel isotope, namely [35S]-cysteine. This
was indeed confirmed when pure [35S]-cysteine was used as a tracer
in the basic experiment.
This observation made it necessary to test whether
incorporation of [35S] in the protein represented incorporation of
the total cysteine molecule or whether cysteine merely acted as a
donor of sulphur atom to a preexisting protein. The results of
the tests to be described next exclude the most common sulphurrelated protein modifications.
First, protein S-thiolation and formation of thio-ester
bonds were unlikely because the radioactive label of the 72 kD
120

protein was retained during (i) boiling for 5 min in 0.1% of SDS
plus 10 to 50 mM of either dithiothreitol or dimercaptoethanol
(which reduces S-S bonds) and (ii) exposure for 18 h to 0.5 M of
hydroxylamine at pH 7 (which breaks thio-ester bonds). Second,
protein tyrosine sulphation, a common protein modification in
eukaryotic cells, but not in bacteria (38), was unlikely because
(i) the 72 kD protein could not be labeled by Na2-[35S]-04 (4) and
(ii) there was no loss of label after exposure to 1 M HC1 for 1 h
at room temperature plus 5 min at 95°C, a treatment which breaks
S-O-tyrosine bonds (37). Moreover, pretreatment of the cells with
the oxidant chlorate (a potent inhibitor of tyrosine sulphation
in eukaryotic cells (4)) did not interfere with in vivo labeling
of the band. Finally, cellular proteins radiolabeled in the 72 kD
band were oxidized with performic acid followed by hydrolysis in
6N HC1 overnight and amino acid analysis. All the radioactivity
was recovered with the material eluting at cysteic acid and/or
inorganic sulphate. The radioactive material recovered from the
amino acid analysis was then separated by paper chromatography in
a solvent capable of separating cysteic acid from sulfuric acid.
The radioactivity was recovered with the cysteic acid fraction
and was apparently not due to contamination with inorganic
sulphate.
Thus, the most common forms of protein modification, such as
S-thiolation (72), formation of thio-ester or thio-ether (such as
lanthionine, which results from the condensation of two
cysteines: COOH-CNH2-CH2-S-CH2-CNH2-COOH) and protein sulphation
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seemed to be excluded. Therefore, labeling of the 72 kD protein
probably resulted from (non-ribosomal?) addition of whole
cysteine residues to the protein, possibly via peptide bonds.

(iii) Regulation of the 72 kD protein labeling. The intensity
of labeling of the 72 kD band appeared to obey some regulatory
mechanism(s) of the cells. Figure 20 (p. 123) shows that after
addition of penicillin, non-growing bacteria labeled the 72 kD
protein for several hours at practically the same rate, as
determined by pulse-labeling experiments. In contrast, however,
as soon as penicillin was inactivated in situ (by addition of
penicillinase to the cultures), labeling of the 72 kD band
sharply decreased, while both synthesis of bulk proteins and cell
division resumed. The decreased labeling of the 72 kD band after
resumption of bacterial growth was not due to a lack of
intracellular tracer, as shown by the fact that radioactive amino
acids were incorporated in all other polypeptides.
This observation was confirmed by 2-D gel electrophoresis, a
technique which allowed a better resolution (figure 21, p. 124).
However, it was not possible to determine whether some labeling
of the band also occurred at some very low percentage of total
radioactive incorporation in normally growing bacteria, because
the area of the 72 kD species was overshadowed by labeling of
other proteins. Labeling of the 72 kD protein also decreased when
penicillin treated cells were starved of the essential amino acid
leucine, a condition which inhibits protein synthesis in non122

Figure 20:

The labeling of the 72 k D protein decreased after inactivation of penicillin
with penicillinase, while synthesis of the other protein species resumed. A
culture of the Lyt" pneumococcal mutant Lyt 4-4 was treated with 20x the
M I C of penicillin and samples were pulse-labeled (for 7 min) with
"Tran^^Slabel" at various time-points of the treatment as described. After 2
h, one portion of the culture received penicillinase (1(P U/ml) to inactivate
penicillin, while the other portion continued to be exposed to the antibiotic.
T h e upper part of the figure shows the autoradiograms of S D S - P A G E s from
lysates of pulse-labeled cells. The lower part of the graph shows the intensities
of the 72 k D band and of so-called "Band 1" (for comparison) as determined
by the "Phosphorlmager". Band intensities are expressed in arbitrary units.
T h e lanes were loaded with equal amounts of total proteins.
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Figure 21:

Shutoff of protein synthesis and labeling of the 72 k D species depicted by 2dimensional (2-D) gel electrophoresis. A cultures of strain Lyt 4-4 (Cid + Lyt")
was treated with 20x the M I C of penicillin followed by inactivation by
penicillinase (after 2h) as described. At several time-points, samples of the
cultures were pulse-labeled with "Tran^Slabel" and processed for 2-D gel
electrophoresis and autoradiography. After inactivation of penicillin with
penicillinase, global protein synthesis resumed, while labeling of the 72 k D
species decreased. The position of the 72 k D radiolabeled protein is indicated
by the arrows. Similar amounts of total proteins were loaded on the gels.
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treated pneumococci (data not presented).
Finally, pulse-chase experiments showed that (i) bulk
proteins radiolabeled prior to penicillin treatment remained
unchanged for up to 4 hours (the duration of follow up) of
penicillin treatment and (ii), the radiolabeled 72 kD protein was
also stable for up to 2 h (the duration of follow up) of exposure
to the antibiotic.

(iv) Labeling of the 72 kD protein in other conditions.
Figure 22 (p. 126) shows that the 72 kD protein was also labeled
during treatment of pneumococci with other, mechanistically
unrelated antibiotics. These included chloramphenicol,
erythromycin, rifampin, streptomycin and the vancomycin
derivative LY-A47934. This protein was similar to that labeled in
response to penicillin, as assessed by identical peptide patterns
generated by partial digestion with V8 protease (see figure 19,
p. 119).
In contrast, however, the DNA cross-linking agent mitomycin
resulted in very poor labeling (if at all) of the protein (figure
22). In addition, the 72 kD protein was not specifically labeled
during heat shock (45°C for 2 h), while two other major protein
species (molecular weight about 50 and 30 kD resp., see figure
23, p. 127) were still being produced in response to this
treatment. Thus, the ability to label the 72 kD protein was
shared by a number of stress conditions, but most interestingly
not by heat shock.
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Figure 22:

Global shut-off of protein synthesis and labeling of the 72 k D band during
treatment of the Lyt" pneumococcal mutant Lyt 4-4 with 20x the M I C of various
antibiotics mechanistically unrelated to penicillin (except for the p-lactamine
cefotaxime). The cells were pulse-labeled at various times with "Tran^Slabel", lysed
and separated by S D S - P A G E before autoradiography as described. Lanes were
loaded with equal amounts total proteins. V - vancomycin derivative, Ctx =
cefotaxime and Str = streptomycin.
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Figure 23:

The 72 k D protein was not produced during heat-shock conditions (45°C)
which resulted in similar bacterial killing than treatment with 20x the M I C of
penicillin. Cultures of Lyt 4-4 in the exponential phase of growth were treated
either with 20x M I C of penicillin (open symbols) or switched to 4 5 ° C (closed
symbols). O D 5 2 0 (squares) and loss of viable counts (circles) in the cultures
were followed (panel A ) . At several time-points during the treatment, samples
were removed from the cultures, radioactively pulse-labeled and processed
for separation by S D S - P A G E and autoradiography as described (panel B).
Lanes were loaded with similar amounts of total proteins.
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(v) Labeling of the 72 kD protein in other organisms. A protein
similar to the 72 kD pneumococcal protein was also labeled during
penicillin treatment of a strain of penicillin resistant
Streptococcus mitis. Figure 24 (p. 129) shows that penicillin
treatment of both Lyt 4-4 and S. mitis resulted in similar
inhibition of global protein synthesis and production of a 72 kD
radiolabeled protein, which produced identical peptide patterns
after partial digestion with V8 protease.
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igure 24:

Treatment of the penicillin resistant S. mitis P e n R with 20x M I C of penicillin
for 2-3 h also resulted in a global shutoff of protein synthesis and labeling of a
unique band that migrated in parallel to the pneumococcal 72 k D on 1 0 %
S D S - P A G E (panel A ) . The similarity between the two bands was further
assessed by identical peptide maps by partial proteolysis with V8-protease
(panel B). The samples were handled and processed as described infigure19.
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Discussion

Two striking observations emerged from the basic pulselabeling experiment described in this chapter (see figure 15, p.
112). First, it appeared that both in Cid+ and in Cid"
pneumococci the decrease in RNA and protein synthesis occurred
with very similar initial rates during penicillin treatment, in
spite of substantial differences (ca. lOOx) in bacterial
survival. Second, both types of bacteria induced and/or continued
the specific radioactive labeling of a unique 72 kD protein with
[35S]-cysteine, even when incorporation of radioactive amino
acids in of all other protein species had come to a virtual halt.
Inhibition of protein synthesis by penicillin treatment has
first been suggested by Hotchkiss (36), in an elegant series of
experiments where he biochemically determined the fate of the
nitrogen atoms of amino acids (provided in the medium) in
penicillin-treated or untreated cultures of Staphylococcus
aureus. However, clear data on bacterial survival were not
provided, and it was difficult to assess whether inhibition of
protein synthesis was due to some sophisticated effect of the
antibiotic or merely to bacterial death. Penicillin-induced
inhibition of macromolecule synthesis was better demonstrated in
later experiments (63), using radioactive precursors and a
penicillin-tolerant strain of Streptococcus mutans (i.e., a
bacterium which was inhibited but neither killed nor lysed by the
drug). It was shown that penicillin treatment resulted in the
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shutoff of both RNA and protein synthesis, and also, to a lesser
extent, in diminished synthesis of DNA.
Since inhibition of protein synthesis renders bacteria
resistant to killing and lysis by cell wall inhibitors, it was
tempting to make some mechanistic association between (i) the
ability of tolerant bacteria to shutoff protein synthesis in
response to the antibiotic and (ii), their capacity to resist the
bactericidal effect of the drug. It was suggested that tolerant
bacteria might more readily shutoff macromolecule synthesis than
non-tolerant cells during antibiotic treatment, in a manner
reminiscent of the stringent response of RelA+ E. coli to amino
acid starvation (24 A ) .
In our experiments, we did not find striking differences
between the initial rates of shutoff of macromolecule synthesis
in penicillin-treated Cid+ and Cid" cultures. Therefore, the
increased survival of Cid+ over Cid' pneumococci was not likely
to be due to a more "stringent" response of the former than the
latter organism. On the other hand, the almost identical decline
of both RNA and protein synthesis during penicillin treatment of
Cid" and Cid+ cultures supported the proposition of Mychajlonka
et al. (63), that some "talk-back" mechanism(s) might exist
between the peripheral process of cell wall synthesis and the
intracellular environment.
Details of this putative signal transduction mechanism are
not known. However, some clue concerning the mediators of this
signaling pathway might be drawn from previous experiments. For
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instance, the fact that neither protoplasts nor stabilized L-form
of bacteria (which may contain at least some penicillin binding
proteins; (48)) are inhibited by penicillin suggest that the PBPs
are not the primary mediators of the downregulation of
macromolecule biosynthesis by the drug. The PBPs, however, are
necessary, because they are responsible for the assembly of the
cell wall, the presence of which is essential for the full
inhibitory response to cell wall inhibitors. It is possible that
some cell wall precursor or metabolite is the primary mediator of
this so-called "talk-back" mechanism. The second element, is
presumably a membrane bound sensor that might perceive the
presence of the primary mediator and transmit a signal to a
secondary intra-cellular effector. This hypothetical mechanism is
analogous to the regulation B-lactamase production in B.
licheniformis and E. coli (41,87).
Beside the improbable assumption of a more stringent
response in Cid" than Cid+ penicillin-treated pneumococci,
another appealing hypothesis was that both types of cells might
produce qualitatively or quantitatively different sets of
"stress" proteins during penicillin treatment. It has been
recently shown in E. coli, that co-expression of up to five heat
shock proteins (68,95) interfered with lysis induced either by
the bacteriophage *X174 E protein or by

treatment with B-lactam

antibiotics. It is noteworthy, however, that heat shock proteins
did not entirely protect the cells from killing by these agents.
In other experiments, Jablonski et al. (39) showed that the
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protein complement of a tolerant strain of Staphylococcus aureus
was altered in the course of treatment with the B-lactam
antibiotic oxacillin. They suggested that the drug might induce
the synthesis of alternative "stress" proteins. However, the
observations were based on silver-stained gels of whole bacterial
proteins (rather than on autoradiograms of pulse-labeled cells)
and it was unclear whether the changes in protein profiles were
due to de novo synthesis of some "stress" proteins or to
processing and/or degradation of preexisting polypeptides.
Our experiments revealed an intriguing and totally
unexpected phenomenon: the appearance of a cysteine-incorporating
protein species, under experimental conditions, when synthesis of
all other proteins had come to a virtual halt. The 72 kD protein
could not be labeled by other amino acids and was not turned off
by treatment of the cells with chloramphenicol. The 72 kD protein
may be a polypeptide that undergoes post-translational
modification through the addition of cysteine molecules that may
occur through a non-ribosomal mechanism, like certain peptide
antibiotics which are produced by multifunctional enzyme
complexes (such as, for instance, in penicillin synthesis (71)).
Enzyme-mediated synthesis of a short polypeptide has also been
recently observed in Streptomyces coelium (92).
The function of the 72 kD labeled protein is unknown. Since
it was labeled in response to several antibiotics resulting in
halt of bacterial growth and polymer synthesis, it is possible
that the 72 kD species is involved in the regulation of the
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coordinate shutoff of cellular metabolism. One argument for such
a possibility is that labeling of the protein was also regulated:
it decreased after removal of penicillin from the medium, while
bacterial growth and synthesis of other proteins resumed.
In conclusion, we used the isogeneic Cid*" and Cid"
pneumococci that were both resistant to penicillin-induced lysis
(Lyt") to look into early biochemical events that follow the
covalent binding of the penicillin molecule to its cellular
protein targets. Our observations clearly eliminate the often
quoted hypothesis that bacterial death is related to a synthetic
imbalance between the synthesis of cell wall (which is inhibited)
and cytoplasmic mass (which was assumed to continue). In fact,
the opposite was observed: penicillin treatment has lead to a
rapid and complete shutoff in the synthesis of all - but one protein species through a mechanism that appeared to be a
reversible and global regulatory process. The unique 72 kD
protein that incorporates [3SS]-cysteine may be part of this
regulatory circuit
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Appendix I

Additional characteristics of the Cid" mutant T6

During the characterization of the Cid" mutant T6, it was
found that growth of the organism in the chemically defined
medium Cden (either in liquid cultures or on agar plates)
required the addition of at least 0.02% (w/v) of yeast extract
(the supplementation used in most experiments was 0.1%). Since
slow bacterial growth can affect susceptibility to penicillininduced killing, it was necessary to test whether yeast extract
was a growth limiting factor which might be responsible for the
Cid" phenotype. This was not the case, because supplementation of
growing cultures of Cid" cells with lOx (1%) the standard amounts
of yeast extract did not influence the Cid" phenotype.
The requirement for yeast extract (Y~) in Cden appeared to
be genetically linked to the Cid" phenotype. Competent Cid' (Y")
pneumococci (strain T6) were transformed with DNA of the Cid*
(Y+) donor strain Lyt 4-4 and selected for the ability to grow on
Cden agar plates lacking yeast extract (Y+ phenotype). The
frequency of transformation to the Y+ phenotype was 0.1 to 1%,
which was identical to that of a control point mutation (Nov)
marker. When tested for penicillin-induced killing, all 50
independent Y+ transformants had regained the Cid* phenotype
along with the Y* character. In contrast, none of 15 Y" control
colonies were Cid+. Conversely, when Cid+ cultures were
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transformed with Cid* DNA and submitted to enrichment cycles with
penicillin, the appearance of Cid" cells was paralleled by that
of Y" bacteria.
The linkage between Cid" and Y" allowed us to examine the
rate of reversion of Cid" (Y) to Cid+ (Y+) . "Young" (18-20 h old)
colonies of Y' cells were suspended in tubes containing 1 ml of
rich medium (Cden + Y) , incubated at 37°C and culture growth was
followed by plating samples in duplicate on Cden agar plates
supplemented or not supplemented with 0.1% of yeast extract.
Figure 25 (p. 138) shows that Y" cells displayed a 3 h lag phase
upon transfer into liquid medium. The Y + revertant were detected
at a frequency of approximately lO^-lO"5 during growth in liquid
cultures. However, while both Y* cells and Y + revertants grew at
virtually identical rates, neither the revertants nor wild-type
pneumococci displayed a 3 h lag phase of growth when grown in
liquid cultures. Complementary experiments showed that this
difference in lag phase was responsible for the progressive loss
of the Cid" (Y) phenotype after multiple freezing and regrowth of
an original Cid" (Y) culture.
We attempted to determine the nature of the factor required
for growth of Y" pneumococci from the composition of the yeast
extract (Difco) provided by the factory. When supplemented in
purified form (either individually or in different combinations),
none of the known components of the extract supported growth of
Y" cells. Therefore, the essential substituent probably belonged
to the unidentified portion of yeast extract. Preliminary ultra136

filtration experiments show that the molecular weight of this
unidentified factor is between 500 and 1000 Daltons.
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total Y- and Y + cells

Y+ revertants

Figure 25:

Reversion of Y" (Cid") cultures to the Y + (Cid + ) phenotype. Young colonies (18'20 h)
of the Y" (Cid") strain T 6 were suspended in 1 ml of rich medium (Cden + Y ) and
incubated at 37°C. At several time-points during the incubation, dilutions of the
cultures were plated in duplicate on Cden agar supplemented with 0 . 1 % of yeast
extract (allowing growth of both Y" and Y + cells; open symbols) or not supplemented
with yeast extract (only allowing growth of Y + revertants; closed symbols). Upon
regrowth in new cultures, the Y + revertants did not show the 3 h lag phase in
bacterial growth observed in Y" cells. Y + revertants also had regained the Cid +
phenotype.
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Appendix II

Control of pneumococcal lytA gene conversion by an heterologous
plasmid delivery system.

The experiment is summarized in figure 26 (p. 140). The E.
coli plasmid pGL80, containing the cloned pneumococcal lytA gene
(14), was expanded in E. coli DH5a and used to transform
(convert) the Lyt" Erm pneumococcal mutant RUP-24 (lytA::em; see
table 1, p. 25) to the Lyt+ phenotype. Transformants were first
screened for DOC lysis, and then tested for erythromycin
resistance.
Figure 26 shows that the results can be of two types. First,
if single cross-over (Campbell-like) recombination occurs, the
Lyt+ transformants should contain both the lytA and the lytA::em
alleles (as a result of insertion-duplication) and their
phenotype should be Lyt+ Erm. Second, if double cross-over (gene
conversion) takes place, the Lyt+ transformants are expected to
have lost the Erm marker, due to the conversion of their lytA::em
allele by the cloned lytA gene. The results showed that the
recombination event was essentially of the second type: all of
nine Lyt+ independent transformants had lost their Erm marker
while acquiring the functional lytA gene. This confirmed that
gene conversion (double cross-over) was more frequent than
insertion-duplication (single cross-over) in this system, and
that pneumococci could process DNA expanded in E. coli DH5a.
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containing the cloned
pneumococcal lytA gene
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\
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T w o possible recombination events
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(loss of the heterologous plasmid).
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(amp is not expressed in pneumococci)

Figure 26:

Control of insertion-duplication versus gene conversion using the heterologous
plasmid p G L 8 0 , containing the cloned pneumococcal fytA gene (see text for
details)
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Appendix III

Analysis of cell wall stem peptides by high performance liquid
chromatography (HPLC).

Compared to susceptible strains, penicillin-resistant
pneumococci (with altered PBPs) often contain major alterations
in the stem peptides network (cross-link) of their peptidoglycan
(19,21). We have tested whether the Cid" phenotype might also be
associated with such type of alterations. Cell walls from both
Cid+ Lyt" (Lyt 4-4) and Cid" Lyt' (T6) pneumococci were purified
as described, digested with amidase and submitted to HPLC
analysis using published methods (18,20).
In brief, 5-10 mg of purified cell walls/ml (in 50 mM of
HEPES pH 7 containing 0.1% of Brij and 0.05% of NaN3) were
digested overnight at 37°C with approximately 20 units of
amidase/mg. The products of the digestion were dried, and the
residual buffer was extracted with acetone. The precipitate was
dried and the peptides were extracted with acetone-isopropanolwater (25:25:50) containing 0.1% of trifluoroacetic acid (TFA).
The solvent were removed by evaporation and the peptides were
redissolved in 0.1% of TFA for analysis.
The chromatographic system was made up of a 721 system
controller, two 510 pumps, a U6K injector and a 730 data module
from Waters Associates, Inc. (Milford, MA). The detector was a
variable-wavelength ISCO V4 detector with a 6-mm path length and
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a 3.5 /il illuminated volume flow cell (ISCO, Lincoln, NE). The
column used was a Vydac 218TP54 (The Separations Group, Hesperia,
CA), and the eluting solvent was a 100 min linear gradient from
0.1% TFA (Pierce Chemicals Co., Rockford IL) to 15% acetonitrile
(Burdick & Jackson, Muskegon, MI) in 0.1% of TFA pumped at a flow
rate of 0.5 ml/min. The eluted fractions were detected by their
Aaxor at which wavelength the amide bonds are the main
chromophores.
The results (figure 27, p. 143) show the absence of
significant difference in the major peaks of the chromatograms.
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Figure 27:

Purified cell walls of the Cid + Lyt' strains Lyt 4-4 (upper chromatogram) and the
Cid" Lyt' strain T 6 (lower chromatogram) were digested with amidase and the stem
peptides were extracted and separated by reverse-phase H P L C . The eluted fractions
were detected by their ^210- Approximately 3x less material was loaded on the
column for Lyt 4-4 (upper chromatogram) than for T 6 (lower chromatogram).
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Appendix IV

Construction of pneumococcal mutants producing increased amounts
of a "nicking" enzyme activity.

In these experiments, we used the method of gene duplication
mutagenesis described in chapter II (see figure 7, p. 58). A
complete EcoRI digest of the wild-type strain R6x was ligated at
the homologous site of the "suicide" vector pVA891 and
transformed back in competent cells of R6x. Transformants were
selected for Erm (the marker of the "suicide" vector) and
screened for increased rates of penicillin-induced lysis.
Two clones (Lys-2 and Lys-30) out of 240 Erm transformants
tested, were lysed faster than the parent R6x when challenged
with 2Ox the MIC of penicillin. The "superlyser" phenotype
(called Lys-2) cotransformed with the Erm marker in backcross
experiments, and was not due to alterations of either the cell
wall or the production of amidase, as assessed by the techniques
described in chapter III. However, when transformed in either of
the Lyt" mutants Lyt 4-4 or Rup-27 (lytA::em::cm) the Lys-2
mutation resulted in a new phenotype: the cultures lost optical
density at an increased rate when challenged with 20x the MIC of
penicillin (figure 11, p. 89 in chapter III). This increased
lysis rate was due to a greater number of breaks (or nicks) in
the cell walls, as compared to control Lyt" cultures. The breaks
could be visualized by electron microscopy (see insets in figure
144

11/ p. 89) and did not result from cell wall solubilization,
because Lys-2 mutants radiolabeled in their cell walls did not
release the radioactive tracer during lysis (as opposed to
amidase-induced lysis).
Cell extracts of the Lys-2 mutants contained an increased
enzymatic activity that could lyse both (i) Micrococcus
lysodeikticus cell walls (a substrate which is resistant to
digestion by the pneumococcal major autolysin amidase; see figure
28, p. 146) and (ii) Lyt" pneumococci, when added to the cultures
along with penicillin (data not presented).
The "nicking" enzyme, overproduced by the mutants, might be
the analog of the "second" murein hydrolyse (a glycosidase)
recently described by Lopez et al. (17,74). However, in Lys-2
mutants, overproduction of the enzyme did not increase the rate
of penicillin-induced killing (see figure 11). This observation
casts new doubts about the importance of "nicking" enzymes in the
cidal effect of penicillin on pneumococci.
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Figure 28:

Lysis of Micrococcus lysodeikticus cells by pneumococcal extracts. Proteins extracted
by LiCl treatment of partially purified pneumococcal cell walls were tested for their
ability to lyse M. lysodeikticus cells embeded in agarose (Kallestad Quantiplate kit,
Chaska, M n ) . Equal amounts of proteins of the extracts were loaded in the wells. The
strains were R 6 x (Lyt 4 ), Lys-2 (Lyt"; fast-lyser), R U P - 2 4 (Lyt-) and T 6 (Lyt"). The
plates were incubated for 48-72 h at 37°C.
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Appendix V

Degradation of RNA during penicillin treatment of Cid+ and Cid'
pneumococci.

In group A streptococci, which are highly susceptible to
penicillin-induced killing while notably resistant to antibioticinduced lysis (see figure 2, p. 16 in introduction), penicillininduced loss of viability has been associated with increased
degradation of cellular RNA

(56). It was suggested that the

killing effect of penicillin might be mediated by some enhanced
nuclease activity in the bacteria.
This hypothesis was tested in Cid+ and Cid" pneumococci. In
brief, cultures of (10 ml) of Lyt 4-4 (Cid* Lyt') and T6 (Cid"
Lyt~) grown in Cden minus uridine (but supplemented with 0.1% of
yeast extract) were labeled for about 6 generation-times with
[3H]-uridine (specific activity and concentration as described in
chapter IV). At an 0DS20 of 0.15, the cultures were thoroughly
washed 2x (by centrifugation) resuspended in nonradioactive
(prewarmed) medium and further incubated (chased) at 37°C. At an
0D620 of 0.25, 20x the MIC of penicillin was added and optical
density and viable counts were followed. At several time-points
before and after the addition of penicillin, 500 fil samples of
the cultures were removed and either (i) TCA-precipitated (for 30
min on ice) by the addition of 4.5 ml of 10% ice-cold TCA, or
(ii) diluted with 4.5 ml of water and boiled for 10 min (Mc
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Dowel, personal suggestion). The samples were then filtered
through glass microfiber filters (Whatman) saturated with a
solution of cold uridine (1 mg/ml). The filters were thoroughly
rinsed with cold uridine-containing water, dried and the
radioactivity was counted in a scintillation counter as
described.
The results are depicted in figure 29 (p. 149). No
significant difference in loss of high molecular weight
radiolabeled RNA was observed between Cid* and Cid" cells, either
in TCA precipitates or in boiled samples (not shown of the
graph).
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Degradation of R N A during penicillin treatment of Cid + and Cid' pneumococci.
Cultures of Lyt 4-4 (Cid + Lyt"; closed symbols) and T 6 (Cid" Lyt"; open symbols)
were pulse-labeled with pHJ-uridine, chased with cold precursors and treated with
20x the M I C of penicillin. Optical density (panel A ) , viable counts (panel B ) and loss
of T C A precipitable radioactivity R N A (panel C ) were followed. The dashed line in
panel A indicate the growth curve of control, untreated cultures.
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Appendix VI

Survival of penicillin-induced pneumococcal protoplasts.

The most compelling evidence for the primary role of
penicillin-induced lysis in the bactericidal effect of penicillin
relies on the classic E. coli K~12 spheroplast experiments by
Lederberg (47). When bacteria were suspended in an osmotically
protective medium (containing sucrose and magnesium) and treated
with penicillin, the cells rapidly converted to wall-less
spheroplasts, that could still perform some vital functions (such
as protein synthesis), and were able to resume growth after
reversal to rod-shaped cells in drug-free medium. In contrast,
penicillin-treated cultures in hypo-osmolar medium lysed and
died. Hence, it was important to test whether osmotic protection
might also prevent penicillin-killing in pneumococci.
Among several different conditions that were tested, we
found that pneumococci could be grown (although growth rate was
slow) and converted to stable protoplasts in C+Y medium
supplemented with 30% of raffinose. Protoplast formation and
stability were tested both by phase-contrast microscopy and 0D620,
and the ability of penicillin-induced protoplasts to resume
growth was evaluated by subculturing dilutions of the master
culture (from 10"2 to 10~8) into tubes containing the same
protective medium supplemented with 1,000 U of penicillinase.
R6x was grown in C+Y supplemented or not supplemented with
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raffinose and treated with 2Ox the MIC of penicillin at an 0D620
of 0.25. In the protective medium, sixty percent of the cells had
converted to protoplasts 30 min after addition of the drug and
>95% after 1 h. The protoplasts were stable for up to 20 h and
even resulted in some increase in optical density (but not
viability). In contrast, R6x grown in non-protective C+Y was
rapidly lysed within 2 h of penicillin treatment (see figure 30,
p. 152). However, in spite of osmotic protection, pneumococcal
protoplasts rapidly lost viability (figure 30 C ) .
It was possible that the inability of protoplasts to resume
growth was not due to alterations of the protoplasts themselves,
but rather to the absence of some cell wall "primer" necessary to
resume wall synthesis. Therefore, the experiments mentioned above
were repeated with the Lyt" strain Lyt 4-4. The results showed
that while Lyt 4-4 did not lose their cell walls and did not
convert to protoplasts, the cultures lost viability at almost the
same rates as R6x. Therefore, the maintained presence of the cell
wall did not provide any more protection against penicillininduced killing in these conditions (figure 30 D ) .
Thus, in contrast to experiments in E. coli K-12, osmotic
protection could not prevent penicillin-induced killing in
pneumococci, suggesting that differences exist between the two
systems.
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Lyt 4-4 (Lyt")
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Figure 30:

Survival of penicillin-induced stable protoplasts of pneumococci. Cultures of either
R6x (Lyt + ) or Lyt 4-4 (Lyt") were grown in plain C + Y (R-) or in C + Y supplemented
with 3 0 % of raffinose (R+). O n e portion of the cultures received 20x the M I C of
penicillin (continuous lines) whereas the other portion was used as a control (dashed
lines). Optical density (panels A and B ) and viable-counts (panels C and D ) were
followed. For determination of viable counts, dilutions of the cultures were inoculated
in tubes containing raffinose-supplemented C + Y and penicillinase. Protoplast
formation was assessed by phase contrast microscopy. In cultures of R6x, > 9 5 % of
the bacteria had converted to protoplasts within the first hour of penicillin treatment.
In contrast, Lyt 4-4 cultures did not convert to protoplasts during penicillin
treatment, whether or not they had been grown in high raffinose C + Y .
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A p p e n d i x VII

Figure 31:

Determination of the molecular sizes and the penicillin-binding affinities of the
P B P s of strain R 6 x (Cid + Lyt+) and of the mutant Cid-1 (Cid" Lyt4").
Cultures in the exponential phase (1 ml) were incubated with [^H] -penicillin at
concentrations ranging from 1-1000 ng of antibiotic/ml for 10 min at 37°C.
A n excess of unlabeled penicillin was then added and the samples were
immediately chilled on ice. The cells were recovered by centrifugation at
12,000 g for 5 min at 4°C, suspended in 50 ul of 50 m M sodium phosphate
buffer (pH 7.0) with 1 % of the detergent Sarkosyl and incubated for 15 min
at 37°C. This treatment resulted in the dissolution of the microorganisms.
Techniques used for discontinuous gel electrophoresis and fluorography were
as described (93). Equal amounts of total proteins were on the gel. The figure
shows that P B P s of both the C i d + strain R 6 x and the Cid" mutant Cid-1
migrated identically on S D S - P A G E and had comparable affinities for
radioactive penicillin as shown by the intensities of the radioactively labeled
band on the autoradiograms. Note that there was an overlap between P B P 1 A
and IB on the autoradiogram at high concentrations of radioactive penicillin
(250-1000 ng/ml). At lower concentrations, P B P I B is not seen because it has
a lower affinity for penicillin than P B P 1A.

154

R6x (Cid+ Lyt+)

PBP

1000

500

250

125

Cid-1 (Cid- Lyt+)
62.5

il 1000

R6x (Cid+Lyt+)
31.25

15.6

7.8

3.9

500

250

125

62.5

Cid-1 (Cid- Lyt+)
1.45! 131.25

15.6

7.8

3.9

1.45!

A p p e n d i x VIII

Figure 32 :

Detection of the 72 k D radiolabeled protein in different fractions of the
cultures or the cell lysates by autoradiography on the Phosphorlmager (left
part of the figure) or on X - O M A T films (center and right part of the figure).
Cultures of the C i d + Lyt" strains Lyt 4-4 in the mid-logarithmic phase of
growth were treated with 20x the M I C of penicillin and pulse-labeled with
Tran-^Slabel, as described, before being processed for autoradiography, (i)
The left part of the figure shows that the 72 k D radiolabeled protein was
essentially absent from the growth medium. Radiolabeled bacteria were
pelleted by centrifugation and the proteins present in the cell-free supernatant
were precipitated (overnight with 1 0 % T C A at 4°C) and resuspended in a
50x smaller volume of 50 m M K P O 4 buffer at p H 7.5. Bacteria were lysed
enzymatically (with amidase) as described. Equal amounts of total protein
were loaded in each lanes, (ii) The central part of the figure shows that after
fractionation of the cell lysates by centrifugation (30 min at 12,000 g), the 72
k D band was found in both the supernatant and the particulate (pellet)
fractions. The lanes at time zero emphasize the fact that the protein profiles
were different in both fractions. The 72 k D radiolabeled band recovered from
the supernatant remained soluble after centrifugation at 40,000 g for 30 min.
(iii) Therightpart of thefigureshows that the 72 k D radiolabeled band was
not released from the particulate (membrane-enriched) fraction by treatment
with 1 M NaCl at 37°C for 30 min. Membranes were recovered by serial
centrifugation as follows: bacterial lysates werefirstcleared by low-speed
centrifugation (4,000 g x 5 min) followed by high speed centrifugation (40,000
g x 30 min) and the pellets were resuspended in K P O 4 buffer (50 m M , p H
7.5) supplemented or non supplemented with 1 M NaCl. After 30 min of
incubation at 37°C, the samples were centrifuged again and the pellets were
processed for separation by S D S - P A G E and autoradiography. Equal amounts
of proteins were loaded in each lanes. Note that experiments in which NaCl
was replaced by LiCl gave similar results (not shown on the figure).
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Summary and conclusion

The first report by Fleming on a mold-produced factor (i.e.,
penicillin) that was capable of lysing and killing Staphylococcus
aureus appeared in the British Medical Journal in 1929. The first
clinical report on the usefulness of penicillin in severe
bacterial infections (in war wounds) appeared 14 years later in
the Lancet, a time at which the molecular structure of the new
drug had not been entirely solved. Since that time, penicillin
and its B-lactam derivatives have revolutionized the impact of
bacterial diseases on our society. Yet, the phenomena of
bacterial killing and lysis produced by treatment of susceptible
bacteria with B-lactams are still not fully understood. The
subject of the present thesis was to reexamine these phenomena
and design new experimental approaches to better understand the
mechanism(s) of penicillin-induced killing and lysis in
pneumococci.
In the early fifties, the nature of the bacterial cell wall
as an anatomically and molecularly distinct part of the bacterium
was demonstrated. At about the same time, the diphospho-uridinelinked muropeptides were discovered in penicillin-treated cells
(the Park peptides). In the mid-fifties, Lederberg observed the
change of penicillin-treated cells of E. coli from rod-shaped
bacilli to osmotically fragile spheroplasts (47). He proposed
that the target of penicillin was the so-called cell wall (just
discovered), in the sixties, first Martin (52A) and then Tipper
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and Strominger (77) proposed that the mechanism of action of
penicillin was based on its structural similarity to the
ubiguitous D-alanyl-D-alanine termini of the precursors of the
bacterial cell wall peptidoglycan. From the mid-sixties to the
mid-seventies, the importance of transpeptidases and
carboxypeptidases (located in the plasma membrane) for the
synthesis of peptidoglycan was recognized. In the following
decade, the family of penicillin-binding proteins (or so-called
penicillin-interactive proteins) was discovered. This led to the
characterization of the molecular targets of the B-lactam
molecules, eventually leading to the cloning, classification, and
solving of the molecular structure of the proteins by X-ray
crystallography as well as to the identification of the active
site residues interacting with the B-lactam molecule (43,67).
However, as to how treatment of bacteria with penicillin
leads to its most impressive effect (i.e., killing and lysis)
remained unclear. An early hypothesis was based on the
interpretation of an aspect of selectivity of the drug, namely
inhibition of cell wall synthesis. The abrupt disintegration of
the bacteria after the addition of penicillin apparently without
interference with the mass increase of the culture has led to the
intuitive notion that killing and lysis were due to the
disruption of a weakened cell wall (inhibited in its synthesis)
by the combined mechanical and osmotic pressure of an expanding
(non-inhibited) cytoplasmic mass. In this model, killing was
eguated to lysis (84).
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With the discovery of murein hydrolases (autolysins) in the
second half of the sixties, the proposal was expanded by Weidel
et al. (91 A) as an "imbalanced growth", i.e., an imbalance
between lytic and synthetic activities of cell wall related
enzymes. More specifically, it was proposed that introduction of
"nicks" (by autolysins) in the preexisting cell wall was an
essential part of the cell wall synthetic mechanism, which
allowed new wall building blocks to be incorporated. The
hypothesis was that inhibition of cell wall synthesis (without
inhibition of autolysis) would automatically lead to the well
known phenomena of lysis and killing.
The discovery of antibiotic tolerance in autolysin-defective
pneumococci (80) provided experimental proof for part of this
hypothesis, i.e., autolysin-defective cells indeed did not lyse
with penicillin, but retained a normal MIC value. However,
subsequent studies with the same system led to the recognition
that the model proposed by Weidel was not be fully correct. It
appeared that the autolysin involved in penicillin-induced lysis
of pneumococci (i.e., amidase) was not essential for cell wall
synthesis and was dispensable for bacterial growth as shown in
bacteria with a number of genetic alterations in the amidase
determinant (lytA), including deletion of the gene (6,81). Thus,
in the case of pneumococci, penicillin-induced lysis was not
mediated by an imbalance between the activities of synthetic and
lytic enzymes, but rather by the deregulated activity of an
autolysin (amidase) that was not reguired for synthesis of a
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structurally "normal" cell wall peptidoglycan.
For these reasons, it was not possible any longer to assume
that penicillin treatment would automatically lead to enzymatic
cell wall damages. It was proposed that penicillin treatment
"triggered" an abnormal cell destructive activity of these
enzymes, through some regulatory defect(s) introduced by
penicillin into the bacteria. A specific version of this model
proposed that the key event in the model may be the release of
autolysin inhibitors (lipoteichoic acids or LTA) into the medium
or the dissociation of an intracellular autolysin-inhibitor
complex in the penicillin-treated cell (82,84).
Although the continued cidal activity of penicillin in
autolysin mutants had been noted (80,84), the slowdown in the
killing

effect of penicillin in lytic mutants led to the widely

held belief that the mechanism of killing was the autolytic
disintegration of the bacteria. The starting point of this thesis
was the reexamination of this guestion. Summaries and
interpretations of the experiments were given at the end of each
Chapter of the thesis. Here, I shall briefly recapitulate the
main findings and conclusions of this work.
The experiments described in this thesis have clearly shown
that in pneumococci (and likely also in other bacteria)
penicillin-induced killing occurs by at least two distinct
mechanisms, (i) one which is autolysis-dependent and accounted
for the loss of about 1 Log unit CFU/ml of culture and (ii) a
second mechanism, which is independent of autolysis by the major
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autolysin amidase and was responsible for the loss of 3-4 Log
units CFU/ml of culture.
The central element of this second mechanism was a genetic
locus (provisionally called the cid locus), which was not linked
to the amidase gene (lytA) that is responsible for the classic
phenomenon of autolysis. Genetic experiments in which the cid"
mutation and the lytA gene were brought together in a

single

cell also revealed that the cid" mutation had at least a partial
controlling effect on the triggering of autolysis by penicillin.
The examination of the cidal and lytic activities in this
context also suggested that the activity of the cid determinant
(i.e., killing) precedes activation of autolysis. These
experiments allow one to suggest a seguence of events, which
begin with the specific binding and inhibition of the membranebound PBPs by penicillin, most likely followed in a rapid
succession by an abnormal course of wall synthesis (94),
production of a regulatory signal(s) which shuts down biopolymer
synthesis; a "killing event" (resulting in the loss of viability)
and - finally - triggering of autolysin activity. A simplified
scheme of such a sequence of events is given on the next page.
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These experiments are consistent with the model proposed earlier
that the primary effect of penicillin is growth inhibition (84).
The construction of Cid" Lyt" double mutants has allowed for
the first time to examine early events in the sequence of
responses following the inhibition of penicillin-binding
proteins. Addition of penicillin to these bacteria, which were
not lysed and suffered only a minor decline in viable titers,
resulted in a rapid and massive shut down in the synthesis of
polypeptides. At the same time, a single and unique 72 kD
polypeptide species began and/or continued to incorporate
radioactive [35S]-cysteine. These surprising and novel
observations may be the first evidence for the existence of a
regulatory circuit between the biosynthesis of cell wall and the
rest of biopolymer synthesis. As discussed in Chapter IV (p. 1312), such a system would involve a primary mediator (made of some
cell wall precursor or metabolite) and a presumably membranebound sensor which might perceive the presence of the primary
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mediator and transmit a signal to an intracellular effector. The
72 kD protein may be part of this circuit and may represent a new
antibiotic-induced stress factor. It is of significance that both
the global shutoff and the labeling of the 72 kD protein were
also observed in other non-lysing streptococcal species.
Extensive comparative experiments were performed using
isogeneic pairs of Cid+ Lyt" and Cid" Lyt" pneumococci, in an
attempt to define the nature of the killing event(s). No
differences were found between these strains in terms of the
complement of their penicillin-binding proteins, muropeptide
composition of their cell walls, sensitivity of their cell walls
to the autolysin amidase, the rates with which cellular proteins
and RNA synthesis decreased after addition of penicillin and the
number and nature of protein components resolvable by 2-D gel
electrophoresis.
Extensive genetic approaches to clone and sequence the cid"
gene have proved so far unsuccessful. Neither shotgun mutagenesis
based on gene insertion-inactivation nor cloning in E. coli
produced the expected gene, in spite of the fact that appropriate
control experiments proved the adequacy of the experimental
systems. It is probably significant, in this respect, that
attempts to clone genetic elements responsible for similar
phenotypes have encountered the same difficulties in
Staphylococcus aureus and in E. coli. The appearance of a new
nutritional requirement in the Cid" mutant used in our
experiments and the close genetic linkage between these two
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markers suggest that null-mutants in the cid determinant may be
lethal because of a normal physiological function of this gene.
Thus, the biochemical nature of the penicillin-induced killing
event in bacteria remains a mystery.
On the basis of more complex experiments we propose that the
cid locus product(s) may operate at the level of the plasma
membrane and might have some analogy with the bacteriophage lytic
systems (96). Specifically, the Cid protein(s) may have a similar
function to the S-protein of lambda phage. It is proposed that
the penicillin-induced overproduction (or deregulation) of the
Cid protein(s) would lead to membrane damage in a manner similar
to the channel- (or hoiin) forming bacteriophage encoded Sprotein aggregates. In Lyt" cells, the membrane damage per se
would be responsible for most of the killing. In the presence of
autolytic enzymes (i.e., in Lyt+ bacteria), the Cid protein(s)
would control (directly or indirectly) the access of these
enzymes to the bacterial cell wall, thus advancing the phenomenon
of viability loss to autolysis.
In order to explain the unique ability of cell wall
inhibitors to trigger this sequence of phenomena, we propose that
the expression of the Cid protein(s) is under negative control by
a repressor, which may be composed of some cell wall material,
cell wall precursors, or some other metabolite (LTA; soluble,
uncrosslinked peptidoglycan oligomers), the synthesis of which is
perturbed in the penicillin-treated cell. In this model, the well
known suppression of the cidal and lytic effects of penicillin by
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inhibition of protein synthesis also requires a new
interpretation: the mechanism is not the prevention of the
increase in bulk cytoplasmic mass, but rather the prevention of
overexpression of a specific (hypothetical) toxic protein(s) (see
figure 13, p. 98).
The kind of cyclic antibiotic exposure used to produce Cid"
mutants in the laboratory was very similar to the kind of
antibiotic pressure operative in the clinical environment, at
least with the classical B-lactams which have relatively short
half-lives (58). Interestingly, a very large proportion of
clinical isolates of penicillin-resistant pneumococci have been
shown to carry traits (resistance to penicillin-induced lysis)
similar to traits in mutants constructed in the laboratory
(49,58). In the case of Enterococcus faecalis, cyclic exposure to
penicillin has led to lysis and kill resistant bacteria. While
Enterococcus faecal is from the pre-penicillin era would be lysed
and killed during penicillin treatment, the kill and lysis
resistance to penicillin is a universal property of most
contemporary isolates of Enterococcus faecal is, suggesting that
in this particular species, penicillin treatment in the clinical
environment may have introduced the

penicillin-tolerance trait

in these bacteria (32A).
The acquisition of a phenotype enabling bacteria to survive
antibiotic treatment has an obvious selective advantage. In
addition, carrying the antibiotic-tolerance trait may make
tolerant cells preferred recipients in genetic exchanges
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involving antibiotic resistance genes. The frequent association
of decreased penicillin-induced lysis (tolerance) and penicillin
resistance (i.e., the ability of bacteria to grow in spite of the
presence antibiotic in the medium) in clinical isolates of
pneumococci may be the result of such a sequence of events (i.e.,
tolerance followed by resistance) in the bacteria (49,58).
The observations and conclusions of this thesis set the
stage for future experimentations in this field and it may be
worthwhile to briefly enumerate key areas that need further
exploration.
As stated above, the nature of the penicillin-induced
killing event(s) is not known. The experiments with the
osmotically stabilized protoplasts suggested that an irreversible
membrane damage might cause loss of viability. It is relevant, in
this regard, that penicillin treatment of bacteria may lead to
the secretion (or shedding) of a number of membrane-associated
molecules, including LTA, phospholipids and proteins (see
3,34,67A,82). It is also possible, however, that the second
pneumococcal autolysin, capable of "nicking" the glycan chain
acts in tandem with the activity of the Cid protein(s) at the
membrane. The experiments with the insertion-duplication mutant
(Lys-2) overproducing this second enzyme showed that it is the
rate of autolysis, and not the bactericidal susceptibility that
is primarily affected in these mutants. This finding is
consistent with the model in which the event determining the rate
of killing is the number of wall "nicks" per cell rather then
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their size.
Further characterization of the Cid" mutants will require
approaches that are complementary to those presented in this
thesis. First, on the biochemical and physiological levels, it
will be important to test whether Cid+ and Cid" cells differ in
their membrane and/or wall content in LTA as well as in the
kinetics of secretion of LTA (and other membrane-related
molecules) during penicillin treatment. LTA is a membrane-bound
molecule which (among other functions) has the capability to
strongly inhibit autolysin-induced cell wall degradation
(3,35,67A,82). Therefore, it is possible that LTA might be
implicated in the inhibition of cell wall degradation by amidase
in Cid" cells.
Second, the molecular characterization of the cid gene (or
locus) is critical because it might give us the opportunity to
investigate both the cid gene product(s) itself as well as the
organization and the control of the cid element(s) in the
bacterial genome. From the negative results of the experimental
systems presented in this thesis, it is clear that the cloning
strategies will have to be different in order to avoid
inactivation and overexpression of the gene. Because of the
potential importance of this molecular genetic approach, it may
be worthwhile to spell out available alternative cloning
strategies in some detail.
Cloning in S. pneumoniae could be attempted by a "gene
rescue" system using the technique of insertion-gene duplication
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mutagenesis with an heterologous plasmid carrying an Erm marker
as described in Chapter II (see figure 7, p. 58). First,
libraries (in the heterologous vector) containing either the cid
or the cid" allele should be created. Second, such libraries
would be used to transform recipient cells containing the other
allele of the gene (e.g., bacteria containing the cid"
mutation - which also confers the Y" phenotype - will be
transformed with libraries containing the cid allele - conferring
the Y+ phenotype). Third the transformants selected for insertion
of the heterologous plasmid (by the acquisition of the plasmid's
Erm marker) could be screened for the parallel reversion of the
Y+ or Y" phenotype (e.g., Y~ to Y+ in the example mentioned
above). Reversion of the phenotype in this situation would
suggest dominance of the wild-type gene (conferring Y+) over the
mutated allele (conferring Y"). The gene may then be cloned by
analyzing the DNA adjacent to the heterologous vector using
standard molecular genetic techniques.
Alternatively, the cid gene might be cloned by generating
libraries of pneumococcal DNA in an E. coli bacteriophage. This
system would avoid overexpression of the target DNA in a
multicopy plasmid. Several techniques (not described here) are
available to recover DNA directly from phage plaques in order to
test its ability to transform either the Cid+/" or the Y+/~
phenotypes into adequate pneumococcal recipient cells.
It would also be important to create additional Cid"
mutants: either conditional mutants or mutants altered in other
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putative genes affecting penicillin-induced killing, which might
be less difficult to clone.
Finally, as to the characterization of the 72 kD protein
labeled by radioactive-cysteine, a first attempt to sequence a
purified peptide fragment resulting from a partial digestion with
V8 protease has failed for technical reasons (the N-terminal of
the peptide was blocked). Purification of the whole protein (as
well as of other peptide fragments) is currently underway.
Determination of a partial sequence of the protein will allow
further investigations at the levels of both the biochemistry and
the molecular biology of this intriguing polypeptide.
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